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Abstract
This dissertation focuses on the synthesis and characterization of glyconanomaterials,
as well as their applications in studying carbohydrate-protein interactions. A new and
versatile method for coupling underivatized carbohydrates to nanomaterials including
gold and silica nanoparticles was developed via the photochemically induced coupling
reaction of perfluorophenylazide (PFPA). A wide range of carbohydrates including
mono-, oligo- and poly-saccharides were conjugated to the nanoparticles with high
yields and efficiency. New analytical methods were developed to determine the
binding affinities of glyconanoparticles (GNPs) with lectins; these include
fluorescence-based competition assay, dynamic light scattering (DLS) and isothermal
titration calorimetry (ITC). Results showed that the multivalent presentation of
carbohydrate ligands significantly enhanced the binding affinity of GNPs by several
orders of magnitude compared to the free ligands. Systematic studies were carried out
to investigate the impact of ligand presentation, i.e., the type and length of spacer
linkage, the ligand density and the nanoparticle size on the binding affinity of the
resulting glyconanoparticles. We used gold GNPs to study interactions with anti-HIV
lectin cyanovirin-N (CV-N), and dye-doped silica nanoparticles for labeling glyans
and developing high-throughput screening technique.

i

Acknowledgements
I wish to express my warm and sincere thanks to my advisor Prof. Mingdi Yan. Her
broad knowledge and logical way of thinking have been of great value for me. The
present dissertation would not have been possible without her understanding,
encouraging and personal supervision.
I want to thank my committee members: Prof. Andrea M. Goforth, Prof. Andres H. La
Rosa, Prof. Shankar B. Rananavare and Prof. Jun Jiao for their generous guidance.
I would like to express special thanks to Prof. Olof Ramström from Department of
Chemistry at KTH- Royal Institute of Technology, Sweden, visiting professors Prof.
Raymond Bard (University of Portland) and Prof. Takuya Kubo (Tohoku University,
Japan) for their kind efforts on providing valuable suggestions and help.
I would like thank my past and current labmates: Dr. Lihong Liu, Dr. Hui Wang, Dr.
Ke Jiang, Dr. Anuradha Tyagi, Suji Uppalapati, Sailaja Chada, Kai Wang, Qi Tong,
Liling Li, Surangi Jayawardena, Jing Yuwen and Xuan Chen. It is a pleasure to work
with them, and discuss about our research. All of my co-workers offered me lots of
help, as well as valuable suggestions to my works. I also want to thank Lingquan Deng
(KTH), Dr. Matei and Dr. Koharudin (U. Pitts) for providing samples for my studies.
I owe my loving thanks to my wife Xiaohua Wang and my parents. Without their
encouragement and great helps it would have been impossible for me to finish this
work.
ii

Table of Contents
Abstract............................................................................................................................ i
Acknowledgements ........................................................................................................ ii
List of Tables .................................................................................................................. v
List of Figures................................................................................................................ vi

1. Introductions ............................................................................................................... 1
1.1 Nanomaterials ...................................................................................................... 1
1.2 Nanomaterials surface functionalization ............................................................. 6
1.3 Glyconanomaterials ........................................................................................... 11
1.4 Synthesis of glyconanomaterials ....................................................................... 13
2. Development of a Photocoupling Method for the Synthesis of Glyconanoparticles
................................................................................................................................. 17
3. Quantitative Analysis of Binding Affinity of Glyconanoparticles with Lectins ...... 44
3.1 Fluorescence-based competition assays ............................................................ 48
3.2 Dynamic light scattering .................................................................................... 51
3.3 Isothermal titration calorimetry ......................................................................... 65
4. Impact of Ligand Presentation on the Binding Affinity of GlyconanoparticlesMultivalency Effect ................................................................................................. 76
5. Applications of Glyconanomaterials in Bioanalysis .............................................. 105
5.1 Signal enhancement study glycan-lectin interactions using anti-HIV lectins. 106
iii

5.2 Labeling native glycans with dye-doped silica nanoparticles ......................... 119
5.3 High-throughput glycan screening on lectin microarray ................................. 136
6. Conclusion .............................................................................................................. 155
References .................................................................................................................. 157
Appendices
Appendix A. List of Publications .......................................................................... 170
Appendix B. Copyright Information...................................................................... 172

iv

List of Tables
Table 1.1 Properties of typical nanomaterials and biomedical applications ................. 3
Table 1.2 Typical complementary functional groups of covalent coupling
chemistries ............................................................................................................... 10
Table 2.1 Coupling efficiency and surface coverage of D-mannose immobilized on Au
NPs using PFPA-disulfide 2 as the coupling agent ................................................. 32
Table 3.1 LOD and KD values of GNP-lectin interactions ........................................... 60
Table 3.2 The thermodynamic parameters of GNP-lectin interactions at 25oC ........... 74
Table 4.1 Coupling yield of mono-, oligo-, and poly-saccharides on Au NPs............. 88
Table 4.2 Binding affinity of different GNPs with Con A ........................................... 94
Table 4.3 Binding affinity as a function of ligand density ........................................... 96
Table 4.4 Binding affinity of GNPs with Con A ........................................................ 100
Table 4.5 Binding affinity of GNPs of varying sizes ................................................. 102
Table 5.1 Affinities for Man2/3 (Kd) and GNP-M2/3 (KD) binding to CVNQ50C ...... 117
Table 5.2 Ligand density and coupling yield of glyco FSNPs ................................... 135
Table 5.3 Lectins and their corresponding carbohydrate binding ligands.................. 145
Table 5.4 Association constants (Ka) of lectins and glycans ...................................... 148
Table 5.5 Apparent KD values of glyco-FSNPs with lectins obtained from supermicroarrays ............................................................................................................ 152

v

List of Figures
Figure 1.1. Modification of nanomaterials surface by non-covalent and covalent
approaches ................................................................................................................. 8
Figure 2.1 Simplified description of phenylazide photochemistry. ............................. 19
Figure 2.2 Synthesis of PFPA-Au NPs and subsequent coupling of α-1,4-mannobiose...
................................................................................................................................. 22
Figure 2.3 Synthesis of PFPA disulfides 1 and 2. ........................................................ 23
Figure 2.4 (a) UV-vis spectra (insert: Au nanoparticle solutions) b) TEM micrographs
(scale bar: 200 nm) of Au NPs (A), PFPA-disulfide-functionalized Au NPs (B), Au
NPs with surface-coupled α-1,4-mannobiose (C), and subsequent treatment with
Con A (D). c) Schematic illustration of the interaction of mannobiose-coupled Au
NPs with Con A, and the formation of Au NP aggregates. ..................................... 30
Figure 2.5 UV-vis spectra of (a) monosaccharide-, and (b) disaccharide-functionalized
Au NPs before and after binding with Con A.......................................................... 34
Figure 2.6 SPR peak shifts of carbohydrate-functionalized Au NPs after treating with
various lectins .......................................................................................................... 36
Figure 2.7 1H NMR spectra of PFPA-disulfide 1 and gold nanoparticles functionalized
with PFPA-disulfide 1 (Au-PFPA) in CDCl3 with TMS (0.0 ppm). ....................... 38
Figure 2.8 FT-IR spectra of PFPA-disulfide 1, gold nanoparticles functionalized with
PFPA-disulfide 1 (Au-PFPA), and Au NPs subsequently coupled with -1,4mannobiose (Au-DiMan).. ....................................................................................... 39
vi

Figure 2.9 Calibration curve obtained by treating various concentrations of D-mannose
with anthrone/sulfuric acid and measuring the absorption at 620 nm. .................... 40
Figure 2.10 D-mannose molecules and Au NPs. .......................................................... 41
Figure 2.11 UV-vis spectra of PFPA-functionalized Au NPs and after treating with
100 nM and 1000 nM Con A. .................................................................................. 43
Figure 3.1. Equilibria involved in the competition binding assay (left). Concentration
dependent fluorescence intensity curve (right) ........................................................ 49
Figure 3.2 (a) Synthesis of silica and Au GNPs: S-GNP and Au-GNP. (b) GNP
aggregation upon addition of lectin ......................................................................... 56
Figure 3.3 (a-d) DLS spectra and TEM images (inserts, scale bars: 50 nm) when 35nm S-M-GNP was treated with varying concentrations of Con A. (e) The particle
size vs. concentration of Con A. .............................................................................. 57
Figure 3.4 The change in particle diameter (D) vs. lectin concentration: experimental
data (circles) and the corresponding Hill fitting curves (lines) for a) 35 nm, b) 110
nm, and 470 nm silica NPs, respectively. The scale bars in the TEM images are a)
50 nm, b) 200 nm, and c) 500 nm respectively. ...................................................... 59
Figure 3.5 Percent increase in particle size (= increase in particle diameter
(D)/original particle diameter (D0) x 100%) vs. concentration of Con A for
various GNPs ........................................................................................................... 61
Figure 3.6 (a) Diagram of ITC cells and (b) Typical ITC data. Top: raw ITC data.
Bottom: binding isotherm curve. ............................................................................. 65
vii

Figure 3.7 ITC graphs of GNP-Man with a) Con A and b) PNA. The experimental data
(solid squares) were fit to theoretical titration curves (solid lines) using the software
supplied by the ITC manufacturer ........................................................................... 69
Figure 3.8 ITC titration graphs of Con A with (a) GNP-Man2I, (b) GNP-Man2II, and
(c) GNP-Man2III. Solid squares: experimental data, lines: fitted titration curves .. 71
Figure 3.9 ITC titration graphs of GNP-Man2 with CV-N MutDB ............................... 73
Figure 4.1 Synthesis of PFPA-thiols a-d. ..................................................................... 79
Figure 4.2 Functionalization of Au NPs with PFPA-thiol and subsequent coupling of
carbohydrates. .......................................................................................................... 87
Figure 4.3 a) UV-vis spectra of AuNP-a-Man upon addition of increasing
concentration of Con A. (b) Absorbance of GNPs at 650 nm vs. Con A
concentration............................................................................................................ 89
Figure 4.4 (a) The fluorescence-based competition binding assay; (b) two equilibriums
established in the system; (c) Cheng-Prusoff equation, where IC50 = concentration
of ligand displaying 50% of specific binding; [M] = concentration of free ligand,
Kd1 = dissociation constant of the free ligand with Con A; and Kd2 = dissociation
constant of GNPs with Con A; (d) fluorescence spectra of the supernatant as a
function of increasing concentration of AuNP-b-Man; (e) concentration response
curve, where the IC50 value was obtained. ............................................................... 91
Figure 4.5 Binding affinity vs. ligand density for Man (a), Man2 (b), and Man3 (c)
with Con A. .............................................................................................................. 97
viii

Figure 4.6 TEM images of gold nanoparticles in 4 different sizes: 7 nm (a), 14 nm (b),
22 nm (c) and 30 nm (d) ........................................................................................ 101
Figure 4.7 Schematic illustration of Con A and GNP ................................................ 103
Figure 5.1 Synthesis of Man2- and Man3-conjugated AuNPs GNP-M2 and GNPM3… ...................................................................................................................... 111
Figure 5.2 UV-vis spectra of GNP-M3 before (solid line) and after (dotted line)
treatment with a) CVNQ50C and b) CVNMutDB. TEM micrographs of GNP-M3
treated with c) CVNQ50C and d) CVNMutDB ............................................................ 113
Figure 5.3 Fluorescence competition assay. a) Schematic representation of binding
scenario. b) Modified Cheng-Prusoff equation based on a competitive two site
binding model, where [M] is the concentration of the free ligand, and Kd1 and Kd2
are the dissociation constants of the free ligand for the glycan-binding sites on
Domains A and B of CVNQ50C, respectively. The data were fitted using the
maximum bound fractions, fBmax1 and fBmax2, corresponding to the two binding sites,
and dissociation constants KD1 and KD2 as adjustable parameters. c) Concentration
response curves of GNP-M2 and GNP-M3 ........................................................... 114
Figure 5.4 Calorimetric titration of a) CVNQ50C (35 M) with Man2 (1.5 mM), and b)
CVNQ50C (50 M) with Man3 (0.64 mM) at 30 oC. The raw data were obtained for
30 and 20 automatic injections, respectively. The integrated curves show
experimental points (■) and the best fit (-). The buffer was 50 mM sodium
phosphate, 200 mM NaCl, pH 7.5, containing 0.02% NaN3 ................................. 116
ix

Figure 5.5 (a) Synthesis of PFPA-functionalized FSNPs, and (b) high-throughput
synthesis of glyco FSNPs ...................................................................................... 125
Figure 5.6 Fluorescence spectra of FITC-doped silica nanoparticles before and after
UV irradiation for 10 min ...................................................................................... 127
Figure 5.7 TEM images after FSNP-Man was treated with E. coli strain ORN178 (a),
or ORN208 (b). Insert: fluorescence image of the corresponding sample ............ 129
Figure 5.8 (a) Preparation of lectin microarray, incubation with FSNP-Man, and
fluorescence imaging. (b) Fluorescence image and (c) fluorescence intensities of
lectin microarray after treating with FSNP-Man. .................................................. 130
Figure 5.9 TEM image of FITC-doped SNPs ............................................................ 133
Figure 5.10 Size distribution of FITC-doped SNPs measured by DLS ..................... 133
Figure 5.11 Fluorescence spectra of FITC-doped silica nanoparticles before and after
UV irradiation for 10 min ….. ............................................................................... 134
Figure 5.12 Fluorescence spectra of FITC before and after UV irradiation for 10
min….. ................................................................................................................... 134
Figure 5.13 Schematics of lectin super-microarray fabrication, and the subsequent
assays with glyco-FSNPs....................................................................................... 137
Figure 5.14 Schematics of (a) high-throughput screening, and (b) competition assay on
super microarrays................................................................................................... 138
Figure 5.15 Interactions of Man2-FSNPs with super-microarray: (a) fluorescence
intensity vs. the printing concentration of Con A (□); (b) fluorescence intensity vs.
x

the concentration of Man2 -FSNPs (○); (c) fluorescence intensity vs. Man2-FSNPs
(1.5 mg/mL) incubation time (inserts: fluorescence images of Con A spots (top
panel) and SBA spots (bottom panel)). The concentration of Man2-FSNPs in (a)
was 1.5 mg/mL, and the printing concentration of Con A was 1 mg/mL in (b).... 143
Figure 5.16 Fluorescence (a) and AFM images (b-d) of a printed Con A spot (1
mg/mL) after incubation with Man2-FSNP (1.5 mg/mL) for 2 h.......................... 143
Figure 5.17 Carbohydrate structures used in this study ............................................. 146
Figure 5.18 Fluorescence image (a, c) and fluorescence intensity (b, d) of lectin supermicroarrays interacting with glyco-FSNPs ............................................................ 149
Figure 5.19 (a) Fluorescence image of a lectin super-microarray after incubating with
Man2-FSNP and varying concentrations of 2-Man2. (b-d) Fluorescence intensities
vs. free 2-Man2 concentration for CVN-Q CVN-M (c) and Con A (d) .............. 151

xi

Chapter 1. Introduction

1.1 Nanomaterials

Research on nanoscience and nanotechnology has increased exponentially over the
past decade, with new investigations and discoveries appearing daily 1. Unique
properties of optical, electronic, magnetic, mechanical, and chemical reactivities have
been discovered and are associated with nanomaterials solely because of their
nanoscale sizes and shapes. These materials serve as model systems providing
fundamental understanding of structure-property relationships at the nanoscale. The
investigations in turn guide the creation of new structures, systems, and devices with
novel properties, functions, and utilities. The interdisciplinary research on
nanomaterials merges the fields of synthetic and materials chemistry, condense-matter
physics, and fabrication engineering, solving problems in materials synthesis and
characterization, and providing core frameworks for biomedical functions 2. While
challenges remain in improving the capabilities of characterization tools at the
nanoscale, and the synthesis of nanomaterials of well-defined size, shape and
composition, progress has already been made beyond fundamental research to the
development of diverse and versatile nanomaterials-based biomedical devices
adopting nanomaterials into current biomedical technologies 3,4. For instance, chipbased microfluidic nanodevices enable high-throughput and exceptionally efficient
analysis of gene sequences, greatly expanding the ability for the characterization of
1

genetic makeup and revolutionalizing the specificity of diagnostics and therapeutics.
Nanomaterials, having at least one dimension smaller than 100 nm, are comparable in
size to many biological molecules. The nanosize dimension allows them to incorporate
into cells for in vitro and in vivo imaging, drug-delivery, and targeting tumor cells 5.
Nanosensors aid early detection and prevention of diseases, and nanodevices, used
remotely and in vivo, show high promise for effective and low-cost home-based
health-care, benefiting the well-being of the entire human society.
The field of nanomaterials is vastly diverse and is evolving rapidly. A great variety of
nanomaterials are synthesized for biomedical applications (Table 1.1); a considerable
number of which are polymeric nanomaterials formed either by applying the
techniques of nanofabrication or via molecular self-assembly. These polymers,
carrying multiple or multifunctional ligands by synthesis or physical encapsulation,
have been used in biomedical imaging, as vehicles for drug delivery, and as scaffolds
in tissue engineering 6. The functionalities on these polymeric nanomaterials are in
general built into the material synthesis rather than by surface functionalization.

2

Table 1.1. Properties of typical nanomaterials and their biomedical applications
Nanomaterials
Intrinsic properties
Category

Examples

Metallic

Au, Ag

SPR

Biomedical applications

Biosensing, drug
delivery, bioimaging

Semiconduct CdS,

Fluorescence,

Immunoassays,

or

CdSe

luminescence

bioimaging, biosensing

Magnetic

Fe3O4

Magnetism

MRI, drug delivery

Carbon-

CNTs,

Electronic and mechanical Drug and gene delivery,

based

Fullerene

properties, conductivity

therapy, biosensing

Metal nanoparticles (NPs) such as Au and Ag NPs are excellent nanomaterials
providing a powerful platform in biomedical applications of biomolecular recognition
and sensing, drug delivery, and imaging 7,8. Au NPs are among the mostly used and
studied nanomaterials owing to their ease of preparation, stability, well-established
surface functionalization chemistry, and their unique optoelectronic properties. The
so-called surface plasmon resonance (SPR) absorption, produced by the collective
oscillation of conducting electrons in the metal NP core upon interacting with the
incident light, is dependent on the NP size and shape, the dielectric property of the
media, and the distance between particles. This provides a unique and convenient
platform for monitoring the molecular recognition event occurring at close to the
3

surface of the nanoparticles. Colorimetric bioassays have thus been achieved based on
the SPR shift when molecular interactions take place at the surface of the
nanoparticles, and have been employed to study fundamental biorecognition processes
including cell-cell communication, enzymatic activity, protein-protein interaction, and
DNA hybridization. When the ligand-receptor interaction causes additional
aggregation of nanoparticles, very large SPR shifts occur producing intense color
changes visible to the naked eyes 9. These optical properties, induced by single
particles or interactions between particles, allow the highly sensitive detection of
molecular binding events. In addition, the SPR absorptions are not subject to
quenching/photobleaching that are frequently associated with organic fluorophores, or
blinking that occurs in quantum dots. An early example was demonstrated by Mirkin
and coworkers using oligonucleotide-capped Au NPs 10. Hybridization of the
complimentary oligonucleotide strands induced the aggregation of Au NPs leading to
a distinct solution color change easily visualized by naked eyes. Numerous examples
can be found in the literature where bioconjugated Au NPs are used as colorimetric
biosensors detecting proteins, viruses, and bacteria at an extremely sensitive level. An
additional advantage of NPs is that the multiple ligands presented on the NP surface
could drastically enhance affinities of specific monovalent interactions via the
multivalent binding between NPs and the biological target. Lin et al. reported that the
observed binding affinity of mannose-encapsulated Au NPs with Concanavalin A
(Con A) was several orders of magnitude higher in comparison with that of mannose
with Con A in solution 11. In the study of Melander et al., SDC-1721, which is a
4

structural fragment of the HIV inhibitor TAK-77 and displays no inhibition activity in
solution, became a potent inhibitor when coupled to 2-nm Au NPs 12. The authors
attributed the enhanced activity to the multivalency effect where multiple ligands
presented on the nanoparticle surface greatly enhanced the overall binding affinity
with the protein.

Besides metallic nanoparticles, quantum dots (QDs) are zero-dimension materials
exhibiting quantum confinement in all three spatial dimensions. QDs have broad
excitation spectra yet narrow and tunable emissions, and have thus been widely used
as optical labels in a wide range of biomedical applications including immunoassays
for proteins, nucleic acids, bacteria and toxin analysis 13,14. Compared with the organic
fluorescent dyes, QDs have additional advantages of high quantum yields and high
photochemical stability, and offer improved detection sensitivity and application
lifetime 15. Magnetic nanoparticles of iron oxides is another type of attractive
nanomaterials that have a long history of investigation and have shown remarkable
potentials in biomedical research, 16-24 including magnetic resonance imaging (MRI)
contrast enhancement 25-27, drug delivery 28-31, hyperthermia 32-34, cell separation 35-38,
and tissue repair 39. Superparamagnetic iron oxide nanoparticles can furthermore
improve the diagnostic value by enhancing the MRI contrast on surrounding healthy
and pathological tissues, increasing the MRI resolution at the microscopic-level 40,41.

5

An inherent feature of nanomaterials is their high surface areas, ie, high surface-tovolume ratio in comparison with their bulk material counterpart. For instance, for a
CdSe QD of ~2 nm in diameter, ~90% of the atoms are located on the surface 42.
Nanomaterials thus have high surface energy resulting from increased surface
curvature and a greater percentage of dangling bonds that lack nearest bonding
neighbors. To minimize the surface energy, nanomaterials tend to adopt a spherical
shape, and in addition, to agglomerate into large particles reducing the surface area
and thus lowering the surface energy. Surface modification/passivation of
nanomaterials is highly necessary where the surface layer serves to reduce the surface
energy and at the same time acts as the protective coating preventing nanoparticles
from agglomerating thus increasing their long-term stability 43. The capping layer can
be further derivatized with additional ligands or functional groups introducing diverse
functions and properties to the nanomaterials 44.

1.2 Nanomaterial Surface Functionalization
Bio-functions and bio-compatibility of nanomaterials are realized by introducing
synthetic ligands or natural biomolecules onto nanomaterials, and combining ligandreceptor biological interactions with intrinsic nanomaterial properties. Common
strategies of engineering nanomaterial surfaces involve physisorption or
chemisorption of desired ligands. Surface modification of nanomaterials follows the
general strategies of non-covalent and covalent approaches (Figure 1.1). The non6

covalent approach is a physisorption process where the ligand is adsorbed to the
nanomaterials via the non-covalent forces, including electrostatic interactions,
hydrogen bonding, and hydrophobic interactions. A popular method of non-covalent
surface functionalization is the so-called steric stablization that involves polymers or
surfactants as the capping layer. The surface coating stabilizes individual nanoparticles,
and at the same time, the steric repulsion inhibits agglomeration by keeping the
nanoparticle dispersion intact. An added benefit of this process is that monodisperse
nanoparticles can be synthesized. The polymer layer adsorbed on the surface of
nanoparticles serves as a diffusion barrier to the growing species, resulting in a
diffusion-limited growth in the subsequent growth of nuclei. Diffusion-limited growth
would reduce the size distribution of the initial nuclei, leading to monodisperse
nanoparticles. Furthermore, polymers as the coating materials provide high-density
functional groups that can be subsequently derivatized with appropriate ligands for
bioconjugation. In the example by Star et. al, a FET device was constructed using
polymer-coated carbon nanotubes (CNTs) for the detection of protein binding 45.
CNTs were coated with a mixture of poly(ethylene imine) (PEI) and poly(ethylene
glycol) (PEG). PEI provided the functional groups, ie, -NH2, for the covalent
immobilization of the ligand, biotin, to CNTs. PEG, on the other hand, served as a
non-fouling coating preventing the non-specific adsorption of proteins on the device,
thus giving much increased sensitivity.

7

Figure 1.1. Modification of nanomaterial surface by non-covalent and covalent
approaches.

The majority of surface functionalization methods are based on the covalent bond
formation, which offers the advantage of robust linkage and the stability of the surface
ligand. If the ligand possesses a functional group that is reactive towards the substrate
materials, it can chemisorb to the nanomaterial surface and yield self-assembled
structures. Typical examples of chemisorption include thiol/disulfide on metals (Au,
Ag, Cu) and semiconductors (CdS, CdSe, ZnS), silanes on oxides (SiO2, TiO2), and
phosphates on metal oxides (iron oxide, TiO2). Depending on the nature of the
substrate material, ligands possessing the corresponding functional groups are chosen
and synthesized. Of the chemisorbed self-assembly systems, thiol/Au is the most
8

studied and used. The process is well-established and it produces well-behaved selfassembled monolayers that are stable, reproducible, and thoroughly characterized. The
system is therefore widely used especially for proof-of-principle studies. The surface
functionalization generally follows a simple solution process where the nanomaterial
is immersed in a solution containing the ligand. The reaction occurs readily at room
temperature. Excess ligands are then removed by rinsing with the solvent leaving
behind nanomaterials that are surface-functionalized with the ligand. A highly
effective surface engineering strategy is the so-called ligand exchange technique
where the ligand of interest displaces the stabilizing capping layer on the nanomaterial.
In this case the ligand should have at least equal or higher affinity than the capping
molecule towards the nanomateiral in order to partially or fully displace them. In the
synthesis of gold nanoparticles by the classic citrate reduction reaction of auric acid,
the as-prepared Au NPs bear the citrate capping layer that can be subsequently
replaced by a thiol or disulfide ligand 46.

Covalent bond formation is also accomplished by reacting the complementary
functional groups on the ligand and the surface of the nanomaterial. In this case, the
nanomaterial is derivatized with a functional group, which then reacts with the ligand
that either possesses the functional group in its native form or is derivatized by
chemical synthesis. Table 1.2 shows typical complimentary functional groups used for
coupling ligands to nanomaterials 47-56.
9

Table 1.2. Typical complementary functional groups of covalent coupling chemistries.
(L: ligand)
Ligand

Substrate

Ligand decorated surface

O
N
O

L

N N
N

10

1.3 Glyconanomaterials

Carbohydrates are the most abundant biomolecules in nature and essential elements in
a wide range of processes in living systems. Besides their use as structural materials
and energy sources, they are to large extents mediating recognition events through
their interactions with proteins and other biological entities. Complex carbohydrate
structures are thus involved in, for example, cell communication and trafficking,
tumor genesis and progression, immune responses, fertilization, apoptosis, and
infection.57-63 Many challenges are, however, associated with the study of these
processes, and the development of glycoscience has been largely hampered by the
complexity and low abundance of the glycan structures involved, and the weak
affinities often associated with carbohydrate-protein interactions. The field has
recently experienced a dramatic upsurge, much on account of the very strong
developments in carbohydrate synthesis, glycan analysis methods, and
nanotechnology.64 New synthetic methods, such as automated strategies and enzymemediated protocols, have resulted in increased availability of complex carbohydrate
structures promoting advances in the entire field.65-67

An important development in the field of glycoscience is the discovery that in
biological systems, carbohydrates bind lectins, i.e., carbohydrate-binding proteins, in a
highly cooperative manner to improve the weak affinity of individual carbohydrate
ligands to the lectin.68-70 This cluster or multivalency effect involves multiple
11

carbohydrate ligands and lectins interacting with each other enhancing binding affinity
by several orders of magnitude. For example, oligosaccharides exhibit higher binding
affinity than monosaccharides towards the same lectin. In the biological system,
lectins associate with cells by interacting with the multiple copies of carbohydrate
ligands on the cell surface, exhibiting binding affinities significantly higher than those
of the interactions between the lectins and the isolated carbohydrate ligands. Although
the quantitative aspect of the multivalency effect is yet to be established, the fact that
multivalency can significantly enhance binding affinity has helped fuel a renewed
interest in fundamental glycoscience and glycomaterial development. Extensive work
has been conducted for conjugating carbohydrates to the scaffolds of proteins,
peptides, lipids, and synthetic polymers.71 Synthetic strategies are applied to control
the number of ligands on the scaffold, the spatial display of the ligands, and the
structure of the scaffold, which in turn impact the binding affinity of the resulting
glycoconjugates with their binding partners. These synthetic multivalent
glycoconjugates could bind to receptors competitively having the potential to serve as
inhibitors displacing natural ligands in the applications of carbohydrate-based drug
design and therapeutics.72 When the scaffold is a flat solid surface, efficient glycan
microarrays can be generated facilitating the development of high-throughput analysis
of ligand-protein interactions in applications of ligand screening and diagnostics.73-80
Nanomaterials as scaffolds for carbohydrate ligand display have recently emerged, and
glyconanomaterials have thus been synthesized, demonstrating great potential in
biomedical imaging, diagnostics, and therapeutics. Compared with molecular scaffolds,
12

nanomaterials as ligand carriers offer a number of attractive features. Nanomaterials,
being small in size, have high specific surface areas and can therefore accommodate
high-density ligands promoting multivalent interactions with their binding partners.
The ligand density can be modulated by the size and shape of the nanomaterial, and
multiple epitopes of the same ligand can be exposed and presented in a threedimensional format. Nanomaterials possess unique optical, electronic, magnetic, and
mechanical properties, as well as chemical reactivities. These properties, together with
their nanosized dimensions allow them to be incorporated into cells for in vitro and in
vivo imaging, drug-delivery, and targeting tumor cells. This opens up a wide range of
possibilities, the potential of which is just emerging.81-85

1.4 Synthesis of glyconanomaterials

Two general strategies for nanomaterial functionalization can be discerned, based on
either non-covalent or covalent protocols. Both approaches are associated with
advantages and drawbacks, although covalent protocols are generally preferred due to
the considerably higher stabilities of the constructs.

1) Non-covalent attachment
A variety of glyconanomaterials based on physisorption of carbohydrate ligands to the
material surface has been reported. The attachment relies on non-covalent interactions,
13

including, for example, hydrogen bonding, Coulombic interactions, and hydrophobic
effects. A method for producing metallic glyconanoparticles through electrostatic
adsorption was reported by Yang et al., in which metal-chitosan nanocomposites were
prepared on a range of different metals, including Au, Ag, Pt and Pd.86 The
nanoparticles were synthesized by reducing metal salts in the presence of chitosan,
resulting in simultaneous ligand adsorption. Rosenzweig et al. synthesized dextrancoated quantum dots (QDs) where negatively-charged carboxymethyldextran was
adsorbed onto QDs by mixing with positively-charged polylysine via electrostatic
interactions.87 As noticed from these examples, a notable advantage of the
physisorption strategy is that the reaction conditions are relatively mild, and minimal
chemical derivatization is required for the nanomaterials substrates and the
carbohydrate ligands. Nevertheless, the physical adsorption is relatively random and
disordered compared to covalent linkages. In addition, the strength of the association
is not sufficiently strong, which may lead to potential bond breakage during
interactions, as well as increased nonspecific or unexpected interactions with the target
molecules. This can significantly affect the specificity and sensitivity in applications
such as biological sensing and recognition. However, as demonstrated in the
mentioned examples, oligomer/polymer-based ligands can to some extent circumvent
the stability problems.

2) Covalent attachment
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The most commonly used method for conjugating carbohydrate structures to
nanomaterials is based on covalent attachment. Among the various nanomaterials, Au
NPs are the most extensively used scaffold materials especially in fundamental studies
due to their ease of preparation, exceptional stability, and high reproducibility.88 Au
NPs of different sizes, shapes, and controlled dispersity can now be synthesized using
simple solution-based methods. The well-established thiol- and disulfide-Au chemistry,
first applied to nanoparticles using a two-phase system by Brust et al., allows the
preparation of Au NPs with well-defined surfaces.89 These surface ligands serve as a
protective layer to provide high stability for the nanomaterials in media ranging from
organic solvents to biological milieus. The chemistry has been widely adopted to
prepare Au NPs modified with various functional groups, and biological molecules
including DNA, proteins, peptides, and carbohydrates have all been successfully
introduced into the system.10,90,91 Penadés et al. reported the first synthesis of
carbohydrate-functionalized Au NPs (glyconanoparticles, GNPs).92,93 The
trisaccharide determinant of the Lewisx (Lex) antigen was derivatized with an
alkylthiol, and Lex-coated Au NPs were prepared by reducing HAuCl4 with NaBH4 in
presence of the thiol-derivatized Lex. Based on this strategy, Au NPs functionalized
with monosaccharides (glucose), disaccharides (maltose), and tetrasaccharides (Ley)
were prepared and applied to the studies of various biological interactions.94,95 Later,
several other groups utilized a similar strategy to produce Au and Ag
glyconanoparticles using thiolated carbohydrates.11,96-100 Furthermore, thiolated
carbohydrate derivatives have been adopted in the preparation of glyco-quantum dots
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(GQDs). 101-103 Additional coupling methods based on the reaction of complementary
functional groups have also been developed to facilitate the conjugation of
carbohydrates other than the thiolated derivatives. Examples include coupling Nhydroxysuccinimide (NHS)-functionalized dextran to amine-functionalized Ag NPs,104
and amine-derivatized carbohydrates to aldehyde-functionalized Au NPs.105
Copyright (2009) Royal Society of Medicine Press, UK

Overall, the objective of my PhD project is as follows:
1. To synthesize glyconanomaterials using the photocoupling strategy to
covalently attach a variety of underivatized carbohydrates onto
nanomaterials;
2. To develop new analytical methods to study the binding affinity of
glyconanomaterials with lectins;
3. To comprehensively investigate the effect of ligand presentation on binding
affinity on glyconanomaterials;
3. To develop applications of glyconanomaterials in bioanalysis, such as lectin
recognition, affinity enhancement, glycan labeling, and high-throughput
screening.
These studies will provide a fundamental understanding of glyconanomaterials, and
illustrate their importance in studying carbohydrate-involved biological interactions.
The methodologies established should benefit the study of bio-functionalized
nanomaterials and enable a wide range of biomedical applications.
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Chapter 2. Development of a Photocoupling Method for the Synthesis of
Glyconanoparticles

This work was published on “Wang, X.; Ramström, O.; Yan, M., A Photochemically
Initiated Chemistry for Coupling Underivatized Carbohydrates to Gold Nanoparticles.
J. Mater. Chem. 2009, 19 (47), 8944-8949”
Reproduced by permission of The Royal Society of Chemistry

17

Carbohydrate structures expressed on cell surfaces are vastly diverse. The matter is
further complicated by the fact that half of all cellular proteins are post-translationally
modified by the addition of structurally diverse and complex glycans with many types
of chemical bonds and branch-chains. Therefore highly desirable for carbohydrate
immobilization are effective coupling chemistries that are general and versatile, can
accommodate ligand diversity and give stable interfaces, and yet are simple and
reproducible. Current coupling methods involve chemical derivatization of
carbohydrate structures to introduce functionality that then react with the functional
groups on the nanoparticles, for example, by chemisorption of thiol-functionalized
carbohydrates on gold nanoparticles.

In this chapter, a new technique has been developed and described for coupling
underivatized carbohydrates on gold nanoparticles. The method is based on the
photochemistry of perfluorophenylazides (PFPA), which upon light activation,
undergoes C-H insertion reaction with neighboring molecules. Phenylazides and
derivatives were the most popular photoaffnity labeling (PAL) agents, due to their
high reaction efficiency, fast kinetics, excellent storage stability and ease of synthesis.
Upon light irradiation, they decompose by releasing N2 to give singlet phenylnitrene, a
highly reactive intermediate which can undergo numerous nonselective reactions
yielding a wide range of products. Three main processes of phenylnitrene reactions are
shown in Figure 2.1: ring expansion, insertion/addition and intersystem crossing
(ISC).106
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Figure 2.1 Simplified description of phenylazide photochemistry.
Because all carbohydrates and glycoconjugates possess C-H bonds, no chemical
derivatization is required and carbohydrate structures can be directly coupled to solid
substrates in their native forms. We have successfully attached monosaccharides and
oligosaccharides on Au nanoparticles using this approach. The immobilized
carbohydrates retained their recognition abilities with lectins, and the binding strength,
measured by the SPR red-shift of Au nanoparticles, was consistent with the binding
affinity of the free carbohydrate with the corresponding lectin. This general coupling
chemistry together with the unique and sensitive optical property of the resulting
nanoparticles serve as a label-free and rapid detection platform readily applicable to
clinical diagnosis, sensing, and ligand screening.
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Metal nanoparticles coupled with biological ligands have been widely used for
monitoring activities of biomolecules and their interactions with ligands.107 A unique
characteristic of metal nanoparticles as the recognition probe is their remarkable and
tunable optical property, the so-called surface plasmon resonance (SPR), determined
by their size and shape, the dielectric property of the media, and the distance between
particles. Colorimetric bioassays have thus been achieved based on the SPR shift when
molecular interactions take place at the surface of the nanoparticles, and have been
employed to study fundamental biorecognition processes including cell-cell
communication, enzymatic activity, protein-protein interaction, and DNA
hybridization.9,108,109 When the ligand-receptor interaction causes additional
aggregation of nanoparticles, significant red-shift of the SPR absorption occurs
producing intense color changes visible to the naked eye.110-113

Naturally occurring carbohydrates, glycoproteins, and glycolipids are present at the
surface of nearly every cell in living systems, and play crucial roles in biological
events as recognition sites between cells and different binding partners. They for
example mediate various phenomena including cell growth, inflammatory responses
or viral infections, and changes in glycosylation are often involved in disease states,
including cancer. Efficient analysis and control of such events are of high importance.
Carbohydrate-based detection platforms have recently emerged as highly useful
analytical and diagnostic tools, and have demonstrated tremendous potential to
superior sensitivity, selectivity, and stability.68,114,115 A key technology requirement in
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receptor/ligand-based sensing and detection is the surface conjugation chemistry that
can effectively couple ligands to solid substrates. Carbohydrate structures expressed
on cell surfaces are vastly diverse and complex. Despite the development of new
synthetic and enzymatic protocols, obtaining large quantities of glycans with the
required functionality and precise glycosylation pattern is still a major challenge.
Highly desirable are effective coupling chemistries that are general and versatile, can
accommodate carbohydrate diversity and give stable interfaces, and yet are simple and
reproducible. Ligands attached to solid surfaces through a covalent bond are more
stable than those that are physisorbed by weaker forces. Of the reported covalent
coupling chemistry, the most popular involves chemisorption of thiolated
carbohydrates on Au nanoparticles.11,105,116-120 Other conjugation methods include
coupling N-hydroxysuccinimide (NHS)-functionalized dextran to aminefunctionalized Ag NPs,104 and amine-functionalized carbohydrates to aldehydefunctionalized Au NPs.105 Coupling chemistry that does not require chemical
derivatization of the carbohydrates is appealing. A few examples have been reported
to conjugate underivatized carbohydrates on flat substrates for microarray construction,
although the protocols have not been adapted for Au NPs. One approach used
hydrazide-modified gold substrates where the hydrazide reacted with the terminal
aldehyde group of the carbohydrates.56,121 A similar approach employed aminefunctionalized surfaces and the coupling with carbohydrates took place by reductive
amination to yield an amine conjugate.122 In both cases, reducing carbohydrates are
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necessary, and for monosaccharides, the coupled products often became acyclic and
lost their binding affinity.

Figure 2.2 Synthesis of PFPA-Au NPs and subsequent coupling of α-1,4-mannobiose.

We have successfully employed PFPAs in surface modification, targeting polymeric
materials that lack reactive functional groups for surface coupling.123-126
Carbohydrates are another class of compounds that are well-suited for the PFPA
photocoupling chemistry. The design of our approach is to prepare PFPAfunctionalized Au NPs which can be subsequently be used to covalently couple, in
principle, any carbohydrate structures by way of the insertion reactions of
photochemically activated nitrene species. (Figure 2.2) This coupling chemistry does
not require chemical derivatization of the carbohydrate, which can be complex when
multiple protection and glycosylation reactions are involved. PFPA has been
successfully utilized to immobilize hyaluronan on polystyrene (PS) beads.127 PS beads
with surface amino groups were treated with NHS-functionalized PFPA, and
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hyaluronan was then attached to the bead surface by UV irradiation. In this chapter,
we report that PFPAs can be employed to conjugate monosaccharides and
oligosaccharides on Au NPs. The surface-bound carbohydrates retained their binding
affinity with the corresponding lectins, and the ranking of binding affinity was
consistent with that observed for free ligands in solution. A colorimetry method was
developed to determine the density of the carbohydrates attached to Au NPs. Results
showed that the coupling chemistry is efficient and high yielding.

Experimental details
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Figure 2.3. Synthesis of PFPA disulfides 1 and 2.
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Synthesis.
PFPA-disufide 1 was prepared following a previously reported procedure.128

11,11'-Disulfanediylbi(undecane-11,1-diyl)bis(4-azido-2,3,5,6-tetrafluorobenzoate)
(PFPA-disufide 2). 11-Mercapto-1-undecanol (90 mg, 0.42 mmol) in absolute ethanol
(15 mL) was titrated with a saturated solution of iodine in ethanol until the brown
color of iodine persisted. The solution was concentrated to 2 mL and then water (15
mL) was added. The solution was extracted using diethyl ether (3 x 15 mL), and the
combined ethereal extracts were washed with brine, dried over NaSO4, and the solvent
was removed under reduced pressure to afford the disulfide 4 as a brown oil. A
solution of 3129 (100 mg, 0.42 mmol) in CH2Cl2 (15 mL) was cooled to 0 oC, and
N,N’-dimethylaminopyridine (DMAP) (5.2 mg, 0.042 mmol) and 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDAC) (88.6 mg, 0.046 mmol)
were added. The disulfide 4 was then added and the solution was stirred for 1 h, after
which the solution was allowed to warm to room temperature, and stirred for 12 h. The
product was recovered by extraction with CH2Cl2. The organic layer was washed with
water, brine, and dried over Na2SO4. Purification of the crude product was carried out
by flash column chromatography with 10/1 v/v hexane/ethyl acetate to afford PFPAdisulfide 2 as clear oil (74.1 mg, 42%). 1H NMR (400 MHz, CDCl3): δ (ppm) 4.36 (t,
J =7.4 Hz, 2H), 2.68 (t, J =7.2 Hz, 2H), 1.76-1.72 (m, 4H), 1.41-1.28 (m, 14H). 13C
NMR (100 MHz, CDCl3): δ (ppm) 159.4, 146.0 (d, JC-F=258 Hz), 140.4 (d, JC-F=255
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Hz), 124.7, 107.1, 63.8, 38.7, 34.4, 31.5, 29.8, 28.8, 28.1, 27.7, 25.1. Anal. Calcd for
C36H44F8N6O4S2: C, 51.42; H, 5.27; N, 9.99. Found: C, 51.50; H, 5.31; N, 10.01.

Sample preparation
The gold nanoparticles were prepared following a modified procedure of the twophase system. A 0.25 mM aqueous solution (100 mL) of HAuCl4 (Aldrich) was heated
to boiling and 1 wt% sodium citrate solution (1.8 mL) was added quickly under
vigorous stirring. The solution was allowed to boil for an additional 5 min until the
color of the solution became dark purple and finally light red. A 1.7 mM solution of
PFPA-disulfide 1128 or 2 in acetone (5 mL) was added slowly to the Au NP solution,
and the solution was stirred for 10 hours when it turned to burgundy color. Toluene
(15 mL) was subsequently added, and the mixture was vigorously stirred for 1 hour
leaving behind a light pink aqueous phase. The toluene layer was then separated,
concentrated to 5 mL using a rotary evaporator at 45 ℃, and then diluted with acetone
(20 mL). The diluted solution was kept in refrigerator overnight, and centrifuged at
14,000 rpm for 30 min. Precipitates were collected and re-dissolved in acetone by
sonication for 1 min, and was further centrifuged. The re-dissolution and
centrifugation processes were repeated 3 times to remove the excess PFPA-disulfide.
The functionalized Au NPs were kept in acetone for storage. To determine the
concentration of functionalized Au NPs, an aliquot of the solution was centrifuged,
and the precipitate collected, dried, and weighed.
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Carbohydrates were coupled to Au NPs according to the following general procedure
using α-1,4-mannobiose as the example. A solution of PFPA-functionalized gold
nanoparticles (1.5 mL) was mixed with 2.9 mM of α-1,4-mannobiose aqueous solution
(0.1 mL, V-Labs) in a short flat beaker. The mixture was covered with a 280-nm longpath optical filter (WG-280, Schott Glass) and was irradiated with a 450-W medium
pressure Hg lamp (Hanovia) for 5 min under vigorous stirring. Centrifugation of the
solution at 14,000 rpm for 15 min separated the mannobiose-attached gold
nanoparticles as precipitates. Excess mannobiose was removed by rinsing the
nanoparticles with water 3 times and centrifugation.

Carbohydrate density determination
A freshly-prepared anthrone solution in concentrated H2SO4 (0.5 wt%, 1 mL) was
added into various concentrations of D-mannose in water (0.5 mL) in ice bath under
stirring. The solution was then heated to 100℃ and stirred for 10 min. After cooled to
room temperature, the UV-vis spectra of the resulting solutions were recorded on a
Perkin-Elmer Lamda 45 UV-vis spectrometer. The absorbance of the solution at 620
nm was measured and the data were plotted against the concentration of D-mannose.
The result was used as the calibration curve for the calculation of the ligand density on
Au NPs. Ligand density experiments for Au NPs were carried out by dissolving
freshly-prepared D-mannose-conjugated Au NPs (0.3-0.5 mg, measured by drying the
Au NPs solution under the reduced pressure) in 0.5 mL Milli-Q water, and the
solutions were treated with anthrone/H2SO4 following the same protocol described
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above.The absorbance of Au NPs were deducted from the total singals measured as
the bakground, and the density of D-mannose immobilized was then determined using
the calibration curve.

Lectin binding assay
The binding affinity of carbohydrates conjugated on Au NPs was evaluated using Con
A according to the following procedure. The binding studies with other lectins (letin
from Griffonia simplicifolia (GS II), lectin from Arachis hypogaea (peanut) (PNA),
lectin from Glycine max (soybean), Sigma) were carried out in the similar manner. In
the experiment, the nanoparticles were incubated in a 10 mM pH 7.4 PBS buffer
solution containing 0.1% Tween 20 and 3% bovine serum albumin (BSA) for 30 min,
centrifuged, and incubated in a pH 7.4 PBS solution without BSA for another 20 min.
The nanoparticles were subsequently treated with 10 μg/mL Con A (from Canavalia
ensiformis (Jack bean), Sigma) solution in pH 7.4 PBS buffer (0.05 mL) containing 10
mM MnCl2 and CaCl2 for 1 hour while shaking. In cases where aggregation was
induced after binding with Con A, the suspension was transferred to a centrifuge tube
and centrifuged at 14,000 rpm for 15 min.

Results and discussion
PFPA-disulfides 1 and 2 were synthesized by coupling PFPA-COOH 3 with the
corresponding diol using EDAC (Figure 2.3). Diol 4 was prepared by oxidizing the
hydroxythiol with I2.130 The two disulfides were chosen differing in the length of the
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spacer linkage. A one-pot procedure was developed to simultaneously synthesize and
functionalize Au NPs with PFPA. Colloidal Au NPs, ~20 nm in diameter, were
prepared using the citrate reduction reaction of HAuCl4. The resulting citratestabilized Au NPs were light red in color exhibiting the surface plasmon absorption
peak at ~520 nm in the UV-vis spectrum. The Au NPs were subsequently
functionalized with PFPA-disulfide (Figure 2.3) via a modified phase-transfer ligandexchange reaction, after which the PFPA-functionalized Au NPs migrated to the
organic phase, indicating that the hydrophilic surface of citrate-stabilized Au
nanoparticles became hydrophobic. The successful functionalization of Au NPs with
PFPA was confirmed by 1H NMR and FTIR (see Figures 2.7 and 2.8 in Supporting
Information). The subsequent coupling of carbohydrates to PFPA-functionalized
nanoparticles was carried out by mixing an aqueous solution of the carbohydrate with
the nanoparticles in acetone, and irradiating the mixture with >280 nm light. FTIR
spectra of the resulting nanoparticles show that the characteristic -N3 absorption at
2125 cm-1 disappeared (see Figure 2.8), indicating that the azido groups were activated.
The mannobiose coated NPs could be redispersed in water without significant change
in optical density due to coating of high-density carbohydrate ligands, and excessive
unattached carbohydrate was completely removed through water rinses. Accompanied
by each step of the surface functionalization is the color change of the nanoparticle
solution, shown in Figure 2.4a where α-1,4-mannobiose was coupled on Au NPs. The
UV-vis spectra of PFPA-Au and mannobiose-Au both underwent red-shifts after
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surface functionalization (8 nm and 4 nm, respectively), likely due to the slight size
growth and the change of environment around the nanoparticles.

The amount of carbohydrate ligands coupled to Au NPs was determined by a
colorimetry method using anthrone/sulfuric acid.131,132 This is a well-established assay
for the quantitative analysis of carbohydrates, and has been adopted in
glyconanoparticle analysis.133 We investigated the ligand density on Au NPs using Dmannose. A calibration curve was obtained by treating various concentrations of Dmannose with anthrone/sulfuric acid, and the absorption at 620 nm was measured
(Figure 2.9 in Supporting Information). Au NPs with D-mannose immobilized were
subjected to the same assay and the absorptions at 620 nm were recorded. The amount
of D-mannose attached to Au NPs was subsequently derived from the calibration
curve, which averaged at 24 nmol/mg Au NPs, or 1,200 molecules per Au NP.
Assuming that D-mannose ligands are close-packed on the NP, the maximal amount of
D-mannose that can occupy on each 20-nm Au NP was calculated to be 72 nmol/mg
Au NPs, or 3,500 molecules per Au NP (see Supporting Information for detailed
calculation). This result corresponds to a surface coverage of 34% of the photocoupled
D-mannose, indicating a fairly reasonable coupling efficiency.
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Figure 2.4 (a) UV-vis spectra (insert: Au nanoparticle solutions) b) TEM micrographs
(scale bar: 200 nm) of Au NPs (A), PFPA-disulfide-functionalized Au NPs (B), Au
NPs with surface-coupled α-1,4-mannobiose (C), and subsequent treatment with Con
A (D). c) Schematic illustration of the interaction of mannobiose-coupled Au NPs with
Con A, and the formation of Au NP aggregates.
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To further investigate the efficiency of the photocoupling reaction, various
concentrations of D-mannose were used when mixing with PFPA-functionalized Au
NPs during light activation. Here PFPA-disulfide 2 was used in the study. The amount
of D-mannose attached to Au NPs was then determined by the anthrone/sulfuric acid
assay described above, and results are summarized in Table 2.1. At lower ligand
loading, the coupling yield was high but the surface coverage was low. As the amount
of added ligand increased, the coupling efficiency decreased whereas the surface
coverage increased drastically before saturating at around 80%. Note that even at low
ligand loading concentration of 100 nmol/mg NPs, high surface coverage (80%) was
obtained while relatively high coupling efficiency of 57% was achieved. The result is
significant that large excess of ligand is unnecessary, which is especially beneficial to
carbohydrates that are difficult or costly to obtain. Moreover, this approach provides a
simple means to control the ligand density on the NPs. Nanoparticles with coupled Dmannose density varying over 3 orders of magnitude can be produced by changing the
amount of the ligand initially added. Note that the amount of D-mannose coupled to
Au NPs functionalized with PFPA-disulfide 2 (57.4 nmol/mg) was higher than that on
NPs functionalized with 1 (31.6 nmol/mg) with the same initial ligand concentration,
demonstrating that the longer spacer increased the coupling efficiency.
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Table 2.1. Coupling efficiency and surface coverage of D-mannose immobilized on
Au NPs using PFPA-disulfide 2 as the coupling agent.
Mannose Added

Mannose Coupled

Coupling Yield

Surface Coverage

(nmol /mg NPs)

(nmol /mg NPs)

(%) [a]

(%) [b]

0.1

0.081

85

0.11

0.5

0.40

80

0.56

1

0.78

78

1.1

5

3.1

61

4.3

10

5.3

53

7.4

50

30

59

41

80

44

56

62

100

57

57

80

120

58

N/A

80

150

57

N/A

80

[a] Coupling Yield = Mannose Coupled/Mannose Added x 100%. [b] Surface
Coverage = Mannose Coupled/Max. Mannose Computed x 100%. The Max. Mannose
Computed is 71.7 nmol/mg NPs for 20-nm Au NPs.

The carbohydrate-functionalized NPs were subsequently subjected to binding studies
with a series of lectins, i.e. carbohydrate-binding proteins, to investigate whether the
coupled carbohydrates retained their binding affinity. Concanavalin A (Con A), a
mannose-binding protein, was used as a model system to test the effectiveness of this
coupling chemistry. At pH>7, Con A is tetrameric, each monomer having one
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saccharide binding site specific for mannose, and to a lesser extent, glucose.114 Upon
treating the mannobiose-Au NPs with Con A, rapid and drastic color change occurred
(D, Figure 2.4a insert), and the UV-vis spectrum of the resulting solution showed a
large SPR red-shift of ~75 nm (D, Figure 2.4a). Simultaneously observed was the
cluster formation causing broadening of the SPR peak and a decrease in the absorption
intensity. The aggregation of the nanoparticles is likely a result of Con A’s multiple
binding sites for mannose bringing together dimannose-modified nanoparticles. Indeed,
TEM micrographs showed that the nanoparticles were discrete and isolated until the
addition of Con A (Figure 2.4b). The tetrameric Con A acted as a crosslinking agent
that agglomerated mannose strongly, forming larger sizes of nanoclusters (Figure
2.4c). A control experiment was carried out where PFPA-functionalized Au NPs were
treated with Con A. No SPR peak shift was observed in the UV-vis spectrum of the
resulting solution (Figure 2.11 in Supporting Information). Therefore the SPR shift
and agglomeration can only be attributed to the carbohydrate ligands on the Au NPs.
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Figure 2.5 UV-vis spectra of (a) monosaccharide-, and (b) disaccharide-functionalized
Au NPs before and after binding with Con A. Only one set of experimental data is
shown here. The experiments were, however, repeated over 5 times and the results
were consistent and reproducible.
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To further investigate the generality of this coupling chemistry and the specificity of
surface-bound carbohydrates, monosaccharides (D-mannose, D-glucose, D-galactose)
and disaccharides (maltose, sucrose, α-1,3-galactobiose) were coupled to the PFPAfunctionalized Au NPs using the same experimental protocol. The resulting
carbohydrate-NPs were subsequently treated with Con A and the UV-vis spectra were
recorded. D-Glucose is a known ligand of Con A with a lower binding strength than
that of D-mannose, and D-galactose is a non-binding ligand for Con A.134,135 The
binding constants vary depending on the measurement methods. In the work of
Mandal et al., the association constants (Ka) of D-glucose and D-mannose were
reported to be 1.96 x 103 M-1 and 8.2 x 103 M-1, respectively, measured by isothermal
microcalorimetry.136 In our studies, the UV-vis spectra of the monosaccharidemodified Au NPs showed the largest SPR red-shift for D-mannose (67.7 nm)
compared to D-glucose (25.2 nm), whereas almost no change was observed for Dgalactose-functionalized NPs (Figure 2.5a). These results correlated well with the
affinity ranking of the free monosaccharides with Con A in solution.136 Similar results
were also observed for disaccharide-functionalized NPs. Maltose, having two Dglucose units, showed a red-shift of 30.1 nm whereas sucrose, containing one Dglucose unit, gave a red-shift of 26.1 nm upon binding with Con A. Almost no change
in SPR absorption was observed for galactobiose which is consisted of two nonbinding D-galactose units (Figure 2.5b).

35

Figure 2.6 SPR peak shifts of carbohydrate-functionalized Au NPs after treating with
various lectins. Each data was an average of 5 samples.

Additional cross-reactivity studies were conducted by treating Au NPs conjugated
with mono- and di-saccharides (D-mannose (Man), D-glucose (Glc), D-galactose
(Gal), α-1,4-mannobiose (DiMan), -1,3-glucobioses (DiGlc), α-1,3-galactobiose
(DiGal) and N-acetyl-D-glucosamine (GlcNAc)), with Con A and 3 other lectins (GSII,
PNA and SBA). The SPR peak shifts were determined from the UV-vis spectra and
are shown in Figure 2.6. The affinity ranking derived from the SPR peak shift directly
correlates with reported solution binding affinity between each carbohydrate and
lectin.68,114 For example, larger shifts were observed for the carbohydrate-lectin pairs
of Gal-SBA, Gal-PNA, DiGal-SBA, DiGal-PNA, and GlcNAc-GSII, which was
consistent with our previous study using a carbohydrate microarray where strong
interactions were also observed for these carbohydrate-lectin pairs.128
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Conclusions
In summary, we have developed a general method for coupling carbohydrates to gold
nanoparticles. The method is based on the photochemically induced CH insertion
reactions of PFPAs, and it does not require chemical derivatization of the carbohydrate
structures. Furthermore, the coupling reaction is fast, taking place in minutes instead
of hours which is needed in most thermally-initiated conjugation reactions. The
coupling efficiencies were high, and surface coverage of over 80% was obtained. The
coupled carbohydrates effectively retained their recognition abilities as demonstrated
by the strong interactions with their corresponding carbohydrate-binding proteins. In
addition, the binding affinities of surface-bound carbohydrates with various lectins
were consistent with those of the free carbohydrates with the corresponding lectins in
solution. The sensitive SPR signal was conveniently used to monitor the surface
chemistry occurred on the nanoparticles, especially in examining the interactions of
surface-bound carbohydrates with their binding proteins where large SPR red-shifts
were observed causing visible color changes of the Au NP solutions. The method
developed can be readily applied to other carbohydrate structures, and we have
successfully coupled oligosaccharides and polysaccharides using the same approach.
This general coupling chemistry together with the convenient optical detection offers
an attractive platform for label-free, rapid, and sensitive detection of carbohydratebased molecular recognition.
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Supporting Information

Characterization of PFPA-functionalized and mannobiose-conjugated Au NPs

Figure 2.7

1

H NMR spectra of PFPA-disulfide 1 and gold nanoparticles

functionalized with PFPA-disulfide 1 (Au-PFPA) in CDCl3 with TMS (0.0 ppm).
38

Figure 2.8 FT-IR spectra of PFPA-disulfide 1, gold nanoparticles functionalized with
PFPA-disulfide 1 (Au-PFPA), and Au NPs subsequently coupled with -1,4mannobiose (Au-DiMan). The azide (-N3) absorption at ~ 2125 cm-1 disappeared after
light activation.
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Mannose density measurement

Figure 2.9 Calibration curve obtained by treating various concentrations of Dmannose with anthrone/sulfuric acid and measuring the absorption at 620 nm.
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Calculation of D-mannose density on Au NP

Figure 2.10 D- mannose molecules and Au NPs

The maximal number of D-mannose molecules on each Au NP is calculated as follows.

Assuming that D-mannose occupies in space by taking the shape of a square, each side
of the square is measured to be ~ 6Å by Chem 3D (CambridgeSoft., Ultra, version 9.0).
The D-mannose molecule is then projected to the surface, and the surface area of each
D-mannose molecule is 36 Å2.

The surface area of one 20-nm Au NP is 1.26 x 105 Å2 (= 4 x 1002).
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The maximal number of D-mannose molecules occupying the surface of one Au NP in
a closely packed manner is 3,491 (=1.26 x 105 Å2/36 Å2).

The volume of each Au NP is 4.19 x 106 Å2 (= 4/3 x 1003).
Assuming that the density of Au NPs equals to that of gold (19.32 g/mol), the weight
of each Au NP is 8.09 x 10-14 mg.
1 mg of Au NPs is equivalent to 0.0205 nmol (1/8.09 x 10-14 x 6.02 x 1023).
The moles of D-mannose on 1 mg Au NP is 71.7 nmol (0.0205 x 3,491).

The D-mannose density of Au NP coated was measured as 24.1 ± 1.7 nmol/mg Au
NPs, and the number of D-mannose molecules is ~1,200 (=24.1/0.0205). And the
estimated surface coverage is ~34% (=1200/3491)
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Control experiments

Figure 2.11 UV-vis spectra of PFPA-functionalized Au NPs and after treating with
100 nM and 1000 nM Con A.
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Chapter 3. Quantitative Analysis of Binding Affinity of Glyconanoparticles with
Lectins

The work in Section 3.1 was published on “Wang, X.; Ramström, O.; Yan, M.,
Glyconanomaterials: Synthesis, Characterization, and Ligand Presentation. Adv. Mater.
2010, 22, 1946-1953”
http://onlinelibrary.wiley.com/doi/10.1002/adma.200903908/abstract
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Glyconanomaterials are synthesized under specific conditions using different
chemistry and reagents. Careful evaluation of these materials must therefore be
conducted to fully characterize the structure, composition, density of surface ligands
as well as biological activities in order to make proper correlation with their
performances. Thanks to the significantly increased specific surface areas of
nanomaterials, conventional chemical analytic techniques that are insensitive to flat
substrates can be readily adopted for nanomaterial characterization. In Brust’s first
paper on the preparation of thiol-capped Au NPs, the products were characterized by
FTIR showing the presence of alkanethiol, and TEM revealing the size and shape of
the nanoparticles.89 With the rapid development of advanced analytical tools,
especially sensitive surface characterization techniques, nanomaterials can now be
analyzed more accurately, providing in-depth understanding of the chemical and
physical properties of glyconanomaterials.137 NMR, surface-enhanced Raman
spectroscopy (SERS), and FTIR offer detailed structural analysis of nanomaterials and
surface ligands. Thermogravimetric analysis (TGA) yields the amount of organic
components on the nanomaterials, from which the ligand densities can be derived.
Elemental analysis and XPS provide information on the elemental composition and
chemical state of the bulk nanomaterials and the surface ligands. A combination of
microscopy techniques of scanning probe (STM, AFM), TEM and small-angle X-ray
scattering (SAXS) reveals the physical characteristics of size, shape, and assembly
behaviors of the nanomaterials.138,139 Caution should be used when analyzing the
results as the experimental conditions applied to each technique (vacuum, ambient,
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solution) can significantly impact the outcome. Microscopic techniques can also be
used to directly visualize the interactions of glyconanomaterials with their binding
partners. In our study, when D-mannose-functionalized iron oxide nanoparticles were
treated with E. coli strain ORN178, the nanoparticles selectively bound to the FimH
lectin on the bacteria, which was clearly shown in TEM.140 The surfaces can
furthermore be characterized by taking advantage of the unique properties offered by
the nanomaterials. A classic example is metal nanoparticles, which exhibit SPR that is
highly sensitive to the surface constituents and can be conveniently monitored
colorimetrically as the molecular recognition event occurs at, or close to, the surface
of the nanoparticles.110

Biomedical imaging, therapeutics, medical diagnosis, and drug delivery are among the
many areas glyconanomaterials have the potential to impact. The interaction of
glyconanomaterials with biological receptors and targets is a critical process involved
in these applications and the binding affinity is thus an important parameter for
evaluating the performance of glyconanomaterials. When a ligand is conjugated to a
solid surface, the structure of the ligand is in a sense altered. The binding affinity of
the free ligand in solution can no longer be used as the substitute for the
glyconanomaterial with the corresponding binding partner. In glyconanomaterials,
multiple ligands are clustered on a single solid entity. Multivalency effect comes in
play whereby ligands act cooperatively enhancing the overall binding affinity with the
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receptor. This multivalency effect is highly sensitive to how the ligands are presented
on the nanomaterial surface, i.e., the number of ligands or ligand density, the structure
and length of the spacer linker, and how the ligand is attached or the coupling
chemistry. Therefore the binding affinity of the glyconanomaterials must be carefully
evaluated taking into consideration these parameters.

Carbohydrate-lectin interactions of free ligands in solution have been studied by many
biochemical and biophysical methods including NMR spectroscopy,141 SPR
spectroscopy,142,143 X-ray crystallography,144,145 titration microcalorimetry,146 and
fluorescence spectroscopy.147 Quantitative analysis of glyconanomaterials is
investigated to a lesser extent, and a few protocols were reported to determine the
binding affinity of glyconanoparticles. Lin and coworkers used SPR to analyze the
multivalent interactions between mannose, glucose, or galactose-encapsulated gold
nanoparticles with Con A.11 A competition binding study was carried out where
equilibria were established between mannopyranoside attached on the SPR sensor,
Con A, and varied concentrations of mannose-encapsulated Au NPs. The dissociation
constant Kd of mannose-Au NPs with Con A was determined to be 2.3 nM,
representing a binding affinity over 5 orders of magnitude higher than that of the free
D-mannopyranoside with Con A in solution (Kd:470 M measured by ITC148). In the
system developed by Wu et al., magnetite-gold core/shell nanoparticles coated with
proteins were allowed to interact with carbohydrate ligands on a glycan array.149 A
magnetic field was applied to amplify the protein-carbohydrate interactions and the
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signals were visualized and quantified using a silver enhancement reagent. Apparent
Kd values of 66 nM, 61 nM and 57 nM were determined for Man1, Man4 and Man9
ligands with Con A, respectively.

3.1 Fluorescence-based Competition Assays
In this part, a fluorescence-based competition assay has been developed to determine
the binding affinity of glyconanoparticles to lectins. In the assay, a fixed concentration
of a free ligand (for example, D-mannose) and varying amounts of ligands bound to
Au NPs were incubated with fluorescein isothiocyanate (FITC)-labeled Con A. The
solution was then centrifuged and the fluorescence intensity of the supernatant was
measured. Two equilibria co-exist in the system: FITC-Con A with free D-mannose
and FITC-Con A with D-mannose bound on nanoparticles (Figure 3.1). Since very
low concentrations of Con A and free D-mannose were used, it was assumed that no
agglomeration occurred. Both interactions are reversible, and steady equilibria are
reached rapidly.
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Figure 3.1. Equilibria involved in the competition binding assay (left). Concentration
dependent fluorescence intensity curve (right). [Man] is the concentration of Dmannose on NPs determined using the anthrone/H2SO4 colorimetry assay described in
the text. Each data point was an average of 3 assays.

In order to obtain the dissociation constant Kd, the concentration of the carbohydrate
ligand on Au NPs must be determined. The colorimetric assay of anthrone-sulfuric
acid was adopted to measure the ligand density on the nanoparticles.133 A calibration
curve was first established using the corresponding free carbohydrate, and the amount
of surface-bound ligand on the Au NPs was subsequently determined. The
fluorescence intensity measured from the competition studies was plotted against the
concentration of bound D-mannose on the Au NPs (Figure 3.1). The resulting curve
fits a typical competition assay for ligand-receptor binding, validating the assumptions
made for the system. The IC50 value was subsequently derived and the apparent
dissociation constant (Kd) calculated using the Cheng-Prusoff equation (eq. 3.1),
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Kd 2 

IC 50
[M ]
1
Kd 1

(3.1)

where IC50= concentration of ligands displaying 50% of specific binding; [M] =
concentration of free ligand, i.e. D-mannose; Kd1 = dissociation constant of free ligand
to Con A; and Kd2 = dissociation constant of surface bound D-mannose to Con A.
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3.2 Dynamic Light Scattering
A number of analytical techniques have been used to monitor the interactions of GNPs
with biological receptors, including UV-vis spectroscopy,150 transmission electron
microscope (TEM),151 surface plasmon resonance (SPR), quartz crystal microbalance
(QCM),152 isothermal titration calorimetery (ITC),94 magnetic resonance imaging
(MRI),153 and fluorescence spectroscopy.154,155 Each technique has its advantages and
limitations, and some methods are restricted to the property of the nanomaterials. For
instance, UV-vis spectroscopy only applies to metal nanoparticles that absorb light by
free electron oscillations. SPR and QCM are generally performed on Au surfaces
where the interactions of nanoparticles with target biomolecules immobilized on Au
surfaces are monitored.

Light scattering is a powerful technique for characterizing particles in solutions. When
a beam of light passes through a colloidal dispersion, the particles scatter the light in
all directions. In DLS, the particles are illuminated with a monochromatic laser. The
intensity of the scattered light fluctuates and the rate is dependent on the size of the
particles. Analysis of the time dependence of the intensity fluctuations yields the
diffusion coefficient of the particles, from which the hydrodynamic radius, or the
diameter, of the particles can be calculated.156 DLS has become a routine analytical
tool for particle size measurement. The technique has also been used to study the
interactions of nanoparticles with other species such as polymers,157 DNA,158-160 and
biomarkers.161 The advantages of DLS are: (1) excellent sensitivity, (2) low-cost, (3)
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easy sample preparation, and (4) fast measurement (data can be obtained in a few
minutes). In this part, we report that DLS is a highly efficient technique to study GNP
– lectin interactions. GNPs of different sizes and particle composition were
synthesized and their interactions with lectins were monitored by DLS. The apparent
association constant (Kd) values were determined from the particle size –
concentration response curves. The impact of the particle size on the affinity of the
GNPs was also investigated. To the best of our knowledge, this is the first report on
the quantitative analysis of GNP – lectin interactions by DLS.

Experimental details
Preparation of silica NPs
Silica NPs were synthesized following a modified Stöber protocol,162 similar to what
was previously described.125 TEOS (2 mL) was added to 200 proof absolute ethanol
(34 mL) followed by NH4OH (35%, 1 mL). The reaction was allowed to proceed at
room temperature overnight with vigorous stirring to yield a white colloidal solution;
the particle size was 35 nm measured by DLS. NPs of 110 nm size was synthesized
following the same procedure except for the amount of reagents added: TEOS (2.8
mL), NH4OH (2.8 mL). The 470-nm NPs were prepared using the seed-growth
method.163 TEOS (1.4 mL) was added to 200-proof absolute ethanol (34 mL) followed
by the addition of NH4OH (35%, 2.8 mL). The reaction was allowed to proceed at
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room temperature overnight with vigorous stirring, after which, additional TEOS (1.4
mL) was added continuously in aliquots of 0.2 mL every 10 min.
Functionalization of silica NPs with perfluorophenyl azide (PFPA)
PFPA-silane (80 mg), synthesized following a previously reported procedure, was
added directly to the Stöber solution prepared above, and the mixture was stirred at
room temperature overnight. The mixture was then brought to reflux under continuous
stirring for 1 h at ~78 oC to facilitate the silanization of the silica nanoparticles with
PFPA-silane.125 The mixture was centrifuged at 12,000 rpm for 30 min, and the
precipitate

was

redispersed

in

the

fresh

solvent

by

sonication.

This

centrifugation/redispersion procedure was repeated three times with ethanol and twice
with acetone.

Conjugation of carbohydrates onto PFPA-functionalized NPs
Our previously reported procedure of coupling carbohydrates onto Au NPs was
followed. Briefly, the dispersion of PFPA-functionalized NPs in acetone and an
aqueous solution of carbohydrate was placed in a flat-bottom dish, and the mixture
was irradiated with a 450-W medium pressure Hg lamp with a 280-nm filter for 10
min. Excess carbohydrate was removed by membrane dialysis in water for 24 hours.
The concentration of the resulting GNPs, ca. 18.4 mg/mL, was determined
gravimetrically after drying the solution under reduced pressure for 3 hours.
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Synthesis of 40-nm Au GNPs
The Turkevich method164 was followed to synthesize Au NPs. An aqueous solution of
sodium citrate (1 wt%, 1.2 mL) was added to a boiling HAuCl4 solution (0.25 mM,
100 mL) under vigorous stirring for 15 min. PFPA-disulfide (Figure 3.2), was
synthesized following a previously reported procedure. A solution of PFPA-disulfide
(25 mg) in acetone (5 mL) was added to the Au NPs solution, and the solution was
stirred for 12 hours. The resulting NPs were centrifuged at 12,000 rpm for 15 min and
cleaned with acetone 3 times. Carbohydrate conjugation followed the same procedure
described above for the silica NPs.

Interaction of GNPs with lectins and DLS measurements
The following general procedure was followed for all GNPs and lectins. GNPs (0.1
mg) were incubated in a pH 7.2 HEPES buffer (10 mM, 0.5 mL) containing 3% BSA
for 30 min. The sample was then centrifuged and the particles rinsed 3 times with the
fresh HEPES buffer. The GNPs were subsequently treated with a solution of Con A
(or RCA120) in pH 7.2 HEPES buffer at different concentrations for 2 hour while
shaking. For DLS measurements, the suspension was diluted to 3 mL using the
HEPES buffer. Each DLS measurement was performed at 20 scans, and was repeated
6 times.
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Results and discussion
Lectin detection using silica GNPs by DLS
GNPs were synthesized using the methods developed previously in our
laboratory.165,166 Briefly, silica NPs and Au NPs of varying sizes, synthesized by the
Stöber method162 and the Turkevich method,164 respectively, were functionalized with
PFPA-silane or PFPA-disulfide (Figure 3.2a). Man and Gal were then coupled to the
NPs by the CH insertion reaction of PFPA by UV activation.106 Con A, a well-studied
lectin that exhibits high affinity for the terminal -D-mannopyranosyl group,114,167
was used to evaluate the DLS technique in studying GNP-lectin interactions. As
demonstrated in our previous studies, Man-functionalized NPs formed aggregates
upon binding with Con A,166 resulting in an overall size increase as observed by
TEM.155
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Figure 3.2 (a) Synthesis of silica and Au GNPs: S-GNP and Au-GNP. (b) GNP
aggregation upon addition of lectin.

To investigate the feasibility of DLS in studying GNP-lectin interactions, Man
coupled on silica NPs (35±4.4 nm in diameter), S-M-GNP, was treated with varying
concentration of Con A (1 nM – 700 nM). The hydrodynamic radius of the resulting
complex was measured by DLS. At 1 nM Con A concentration, there was no obvious
increase in the average particle size (Figure 3.3a). When a higher concentration of Con
A was added (50, 70, and 170 nM, respectively), the median diameter of the resulting
particles increased to 55.1±4.5, 64.3±9.5 nm, and 94.8±14.6 nm, respectively (Figure
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3.3b-d). Also increased is the error margin suggesting that particles become more
polydisperse with the addition of Con A.

Figure 3.3 (a-d) DLS spectra and TEM images (inserts, scale bars: 50 nm) when 35nm S-M-GNP was treated with varying concentrations of Con A. (e) The particle size
vs. concentration of Con A.

The sensitivity of the DLS detection was next studied. The limit of detection (LOD),
defined as the lowest analyte concentration measurable against the background, was
determined from Equation 3.2,

LOD 

3
b

(3.2)

where is the standard deviation of the spectroscopic signals of the blank sample
(from 12 measurements), and b is the slope of the linear calibration curve.168,169 Using
the data from Figure 3.3e, the LOD of Con A by the 35-nm S-M-GNP was calculated
to be 2.9 nM.
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To investigate the generality of this method with respect to the nature of the particles,
Au NPs (40 nm in diameter) were synthesized, and Man was then coupled onto the
particles.155 The resulting Au-M-GNP was treated with varying concentrations of Con
A and the particle sizes were monitored by DLS, from which a calibration curve was
established. The LOD was then calculated according to Eq. 1, which yielded 15 nM.
This value was higher than that of the 35-nm S-M-GNP determined by the same
method (2.9 nM), indicating that the Au GNPs were of approximately 5 times lower
sensitivity than the silica GNPs in detecting Con A. However, the method was more
sensitive than the SPR-based optical detection where the LODs were in range of 80100 nM for 13-16 nm Au-NPs.150,170

Titration experiments were next carried out to quantitatively analyze GNP-lectin
interactions. A fixed amount of the 35-nm S-M-GNP was incubated with varying
concentrations of Con A, and the DLS graphs of the resulting solutions were recorded.
The increases in particle diameter,

D, were computed and the results plotted against

the concentration of Con A (Figure 3.4a). The saturation curve was then fitted with an
overall binding model, i.e., the Hill Equation (Eq. 3.3),

Bmax * X h
Y
KDh  X h

(3.3)

where Bmax is the maximum specific binding, KD is the apparent dissociation constant,
and h is the Hill coefficient. The KD value was subsequently derived as 63 nM for SM-GNP (Table 3.1). Following the same procedure, the KD value of Au-M-GNP was
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determined to be 86 nM (Table 3.1). These values represent more than 3 orders of
magnitude increases in binding affinity than that of the free ligand Man with Con A
(Kd = 470 M).148 The results are consistent with our previous studies that NPs can
serve as an efficient multivalent scaffold greatly amplifying the affinity of the bound
ligands with lectins.155 In all cases, the h values were larger than 1, indicating a
positive cooperativity of the ligands conjugated on GNPs.

Figure 3.4 The change in particle diameter (D) vs. lectin concentration: experimental
data (circles) and the corresponding Hill fitting curves (lines) for a) 35 nm, b) 110 nm,
and 470 nm silica NPs, respectively. The scale bars in the TEM images are a) 50 nm,
b) 200 nm, and c) 500 nm respectively.
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Table 3.1 LOD and KD values of GNP-lectin interactions.
GNP

S-M-GNP

Au-M-GNP
S-G-GNP

Diameter
Number of
(nm)
ligand per NP

Lectin

35

830

110

2600

470

4900

40

950

Con A

35

830

Con A

35

840

RCA120

Con A

LOD
(nM)

KD (M)

h

2.9

0.063

3.9

42

0.97

1.6

6.2 x103

9.2

2.3

15

0.086

2.2

N/A
6.6

0.22

1.9

N/A: not applicable.

Impact of NP size on binding affinity
Size-dependency has been recognized as of high significance affecting the physical
and chemical properties of NPs, including adsorption, bio-affinity and catalysis.171-173
To study the impact of the particle size on the binding affinity of GNPs, silica NPs
with an average diameter of 35, 110, and 470 nm, respectively, were synthesized.
Particles of 35 nm and 110 nm in size were obtained by varying the reagent
concentrations using the Stöber method.162 The 470 nm particles were prepared using
a seed-growth method.174 These particles were uniform in shape and size (see TEM
images, Figure 3.4), and were more monodisperse than the Stöber particles as
demonstrated by a narrower particle size distribution for the 470 nm nanoparticles.
Man ligands were subsequently conjugated on these silica NPs following the same
protocol as described above, and the ligand densities were determined by the
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colorimetric method using anthrone/H2SO4. As the size of the NPs increases, the
number of coupled Man increases (Table 3.1), which is expected since the bigger
particle has a larger surface and can thus accommodate more ligands.

Figure 3.5 Percent increase in particle size (= increase in particle diameter
(D)/original particle diameter (D0) x 100%) vs. concentration of Con A for various
GNPs.

The GNPs were then treated with varying concentrations of Con A, and the percentage
increase in particle diameter was calculated from the DLS measurements, shown in
Figure 3.5. A noticeable change in the particle diameter was observed for the 35 nm SM-GNP when 20 nM Con A was added. The particle size did not change for the 110
nm and 470 nm S-M-GNP until the Con A concentration reached 50 nM and 5 M,
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respectively, indicating that smaller NPs were more sensitive in detecting GNP-lectin
interactions. This is consistent with the LOD results determined for these GNPs,
which were 2.9 nM, 42 nM, and 6.2 M for 35 nm, 110 nm, and 470 nm S-M-GNPs,
respectively (Table 3.1). This size-dependent phenomenon was also observed by Huo
and coworkers where Au NPs were used to detect DNA by DLS.158 Titration
experiments were subsequently carried out on all GNPs synthesized, and the apparent
KD values were determined from the saturation binding curves in the same manner as
shown in Figure 3.4. For S-M-GNP, the binding affinity decreased, i.e., the KD values
increased with increasing particle size (Table 3.1). This is in agreement with our
previous studies using Au GNPs where the affinity of GNPs with lectins decreased
with increasing particle size.155 A possible explanation for the lower LOD and binding
affinity of the larger GNPs is the steric hindrance imposed by the larger particles.
Although there are more ligands on the larger particles (Table 3.1), these ligands are
less accessible to the lectin as compared to smaller particles with the same length of
the spacer linker.

The DLS method is also highly specific. When Gal, a non-binding ligand for Con A,
was conjugated to the 35-nm silica NPs and the resulting S-G-GNP was subsequently
treated with Con A, no obvious change in particle size was observed at all Con A
concentrations up to 5 M (Figure 3.5). S-G-GNP was then treated with RCA120, an
R-type lectin exhibiting broad specificity for the terminal galactose group.175 RCA120
is a dimer having one active Gal-binding site on each subunit.176 The lectin can
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therefore act as a crosslinker forming a complex with Gal-coated NPs.177 Indeed, when
S-G-GNP was treated with RCA120, aggregates formed and the size of which could be
monitored by DLS. Following the same procedure as described above, the LOD of
RCA120 was measured to be 6.6 nM, which is on the same order of magnitude as that
of S-M-GNP/Con A system (2.9 nM, Table 3.1). Titration experiments were then
carried out, and the particle size changes were plotted against the RCA120
concentration. The apparent KD was then calculated by fitting the saturation curve
with the Hill equation (Eq. 3.3). The value, 0.22M (Table 3.1), corresponds to an
affinity enhancement of over 4 orders of magnitude in comparison to that of the free
Gal with RCA120 (Kd = 455 M).176

Conclusions
In summary, a new method, based on DLS, was developed to study the interactions of
GNPs with lectins. The method relies on the particle size growth of GNPs, resulting
from the multiple binding sites on lectins that act as crosslinkers bringing GNPs
together to form larger aggregates. Two GNP-lectin systems, M-GNP with Con A and
G-GNP with RCA120, were investigated and the particle size growth was observed
only for the specific binding pairs. The technique is highly sensitive, and the LOD was
on a par with values obtained by other techniques. Quantitative analysis is also
possible from the titration experiments, from which the apparent KD values were
obtained. The results showed that the binding affinities of GNPs with lectins were 3-4
63

orders magnitude higher than that of the free ligands, demonstrating that NPs are an
efficient scaffold amplifying the glycan-lectin interactions. The effect of particle size
was also studied, and results demonstrate that smaller GNPs gave higher detection
sensitivity as well as binding affinity. The method is applicable to both Au and silica
NPs, and is therefore general regardless of the nature of the particles. The high
sensitivity of the DLS method comes from the crosslinking ability of the lectins,
which can be a limitation. However, many lectins contain more than 2 subunits and
can act as crosslinkers inducing particle aggregation. The method developed here,
coupled with the simplicity and fast measurement of the DLS technique, is therefore
highly valuable in studying GNP-lectin interactions.
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3.2 Isothermal Titration Calorimetry (ITC)

Figure 3.6 (a) Diagram of ITC cells and (b) Typical ITC data. Top: raw ITC data.
Bottom: binding isotherm curve.178

In this chapter, an ITC-based method has been developed for determining the
binding affinity of glyconanoparticles with lectins. ITC is a sensitive and
quantitative analytical technique that determines the thermodynamic parameters of
binding events occurring in solution. By measuring the heat absorbed or released
upon the interactions between ligands and biomacromolecules, the binding
constant (Ka), enthalpy of binding (△ H) and stoichiometry of binding (n) can be
derived simultaneously.179 The working principle of ITC is based on heat
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measurement between a reference cell and a sample cell where the binding actually
occurs (Figure 3.6a). During the experiment, the temperature of the sample and
reference cell is adjusted to be the same by supplying or absorbing heat to the
sample cell, and the amount of heat absorbed/released is recorded by a sensor,
which is attributed to the interaction heat in sample cell. The raw data was
obtained by plotting the quantity of heat versus time. Subsequently, heat was
integrated as function of molar ratio between the injectant, e.g., Con A, and its
binding partner, e.g. GNP-M, to give the binding curve (Figure 3.6b). Current
commerical ITC instrument is capable of measuring a wide range of interactions
with Kd values ranging from millimolar to nanomolar. Based on the results from
literature11,152 and our previous studies,155,180 apparent dissociation constants of
GNP-lectin interactions were mostly in the nanomolar range, and therefore, ITC
should be a suitable method for measuring GNP-lectin interactions.178

Experimental details
Preparation of gold glyconanoparticles.
AuNPs, 22 nm in diameter, were prepared and functionalized with PFPA-disulfide
following the same procedure as described in Chapter 2.155 The subsequent
carbohydrate coupling was carried out photochemically as described in Chapter 2.181
Briefly, a solution of PFPA-functionalized AuNPs in acetone (10 nM) mixed with an
aqueous solution of carbohydrate (10 mM) was irradiated for 12 min with a 450-W
medium pressure Hg lamp (Hanovia) with a 280-nm long-path optical filter. The
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resulting GNPs were then dialyzed overnight to remove excess carbohydrate. Before
the binding experiments, the GNPs were incubated in HEPES buffer containing 0.01%
Tween 20 and 3% BSA for 1 hour, centrifuged, and placed in the buffer without BSA
until further use.

ITC
ITC experiments were performed using an ITC200 microcalorimeter from
Microcal, LLC. (Northampton, MA) in HEPES buffer. The concentration of lectin
was 10 M, and that of GNP was 2.5 mM. In each experiment, ~38 L of lectin
was injected through the computer-controlled 40-L micro-syringe at an injection
interval of 4 min into the nanoparticle solution (cell volume = 200 L) while
stirring at 1000 rpm. The experimental data were fitted to a theoretical titration
curve using the software supplied by MicroCal. A standard one-site model was
used with ΔH (enthalpy change, in kcal/mol), Ka (association constant, in M-1), and
N (number of binding sites) as the variables.

Results and discussion
GNPs were synthesized by coupling carbohydrates to Au NPs using the
perfluorophenyl azide (PFPA) photocoupling chemistry developed in our
laboratory.165,181

106,140

AuNPs of 22 nm in diameter were synthesized and

functionalized with PFPA (see Supplementary Information for detailed synthesis).
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D-Mannose (Man), D-galactose (Gal), and -1,2-mannobiose (Man2) were then
conjugated to the PFPA-functionalized AuNPs by light activation.165,181 The
density of the attached carbohydrates were determined colorimetrically using the
anthrone-sulfuric acid assay (Table 3.2).181 Binding studies were carried out using
a plant lectin Concanavalin A (Con A), a well-studied tetrameric protein having
specific binding site for the terminal -mannosyl groups.167,114 In the ITC
experiments, the lectin was loaded into the micro-syringe and was titrated into the
GNP solution placed in the calorimeter cell. When the binding occurs between
GNPs and lectin, such as Man-conjugated GNP (GNP-Man) and Con A, heat will
be released upon each injection. The amount of generated heat decreases with each
subsequent injection as the GNPs in the cell are consumed with bound lectin. In
contrast, if a non-binding lectin is used, the released heat, likely produced due to
reagent mixing, will be small and will remain constant with each injection.
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Figure 3.7 ITC graphs of GNP-Man with a) Con A and b) PNA. The experimental
data (solid squares) were fit to theoretical titration curves (solid lines) using the
software supplied by the ITC manufacturer.

Figure 3.7a is a typical ITC titration graph of GNP-Man with Con A at pH 7.6 in
HEPES buffer containing 1 mM Mn2+ and 1 mM Ca2+. As expected, heat was
generated after each injection of the lectin solution, and the amount of the released
heat decreased gradually with each additional injection. Because heat can also be
produced just by mixing the reagents, background heat from dilutions and was
substracted from each titration experiment. Figure 3.7a (bottom) shows the
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processed titration data (solid squares) and the computed integrated curve (line)
which fit the data points well. The thermodynamic parameters, including
dissociation constant (KD), the enthalpy change (ΔH), the entropy change (ΔS), and
the number of binding sites (n) are shown in Table 3.2. The Gibbs free energy
changes (ΔG) was calculated by standard thermodynamic equation: ΔG= ΔH- TΔS.
The enhancement factor , defined as log (Kd/KD), can be used to evaluate the
multivalency effect when nanoparticles are used as the scaffolds.69,182 Compared to
the binding affinity of the free -D-mannopyranoside ligand with Con A (Kd = 470
M),136 the KD value of GNP-Man with Con A (KD = 122 nM) was closed to 4
orders of magnitude smaller, i.e. the affinity was 4 orders of magnitude higher. The
number of binding sites, N (=1/n), represents the number of sites on the
nanoparticle that were available for binding with the lectin. Note that N (306) is
smaller than the number of carbohydrate ligands immobilized on the particle
surface (3600), meaning that only a portion of available ligands on the GNP
participated in binding the lectin. This is expected considering that the distance
between each of the four monomeric binding site on Con A is 6.5 nm,183 which is
far greater than the distance between Man ligands on the GNP surface (2~3 nm).155
The results indicated the binding of GNP wih lectin is exothermic process (ΔH< 0
and ΔS<0), and an overall negative Gibbs free energy gain (ΔG) was obtained due
to the slight difference between unfavorable entrophy and enthalpy changes. In the
control experiment where PNA lectin was titrated into GNP-Man, the released heat
was small and remained unchanged throughout the titration (top, Fig. 1b).
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Subsequent data fitting gave a flat titration curve (bottom, Fig. 1b). Similar results
were also obtained when Con A was titrated into GNP-Gal where galactose is a
non-binding ligand for Con A. These results demonstrated that there was no
apparent binding between the non-interacting GNP-lectin pairs.

Figure 3.8 ITC titration graphs of Con A with (a) GNP-Man2I, (b) GNP-Man2II, and
(c) GNP-Man2III. Solid squares: experimental data, lines: fitted titration curves.

To study the effect of ligand density on lectin binding, ITC experiments were
carried out where the ligand density on GNP-Man2 was varied from 1400 (GNPMan2I, Figure 3.8a,), to 260 (GNP-Man2II, Figure 3.8b) and 110 (GNP-Man2III,
Figure 3.8c), which were prepared following a mixed ligand strategy.155 GNP-M2I,
having the highest ligand density, gave the largest N value and the highest binding
affinity (Table 3.2). Although GNP-M2I has 5 times and 13 times more ligands
than GNP-M2III and GNP-M2III, respectively, the binding affinity was only 2
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times and 5 times larger. This may be attributed to the fact that not all ligands
participated in binding the lectin.155 GNP-M2III had a slightly smaller N value
than GNP-M2II. However, it gave a slightly more favorable thermodynamic values
(ΔH and ΔG) probably due to the reduced steric hindrance at lower ligand density.
The method was further tested with a bacterial lectin, cyanovirin-N (CV-N).184-187
GNP-Man2 was used since Man2 is an epitope ligand for CV-N. MutDB, a variant
of CV-N and having only one active domain188 (instead of two in the wide-type
CV-N), was used in this study. Results from the ITC titration curves (Figure 3.9)
show 4.6 orders of magnitude affinity enhancement () of GNP-Man2I over free
Man2 to CV-N (Table 3.2), similar to the results obtained previously using a
fluorescent competition assay.189
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Figure 3.9 ITC titration graphs of GNP-Man2 with CV-N MutDB
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Table 3.2 The thermodynamic parameters of GNP-lectin interactions at 25 oC.
Ligand
density
KD/
Lectin
(per
nM
NP)

GNP

GNPMan

3600

Con A 122

Kd/
M

-ΔG/
- ΔH/ kJ
a kJ mol
mol-1
1

470 3.6 137

Nb

-107760 -107623 0.00327 306

NDc

3500 Con A

I

1400

34.8

GNPII
Man2

260

Con A 82.6

III

110

175

GNPMan2

n

NDc

PNA
GNPGal

TΔS/ kJ
mol-1

2.8 18.3

-46356

-46338 0.00478 209

2.5

6.5

-28407

-28401 0.0101 99

2.1 59.2

-30577

-30518 0.0121 83

1400 CV-N 17.2 757188 4.6 47.1

-6650

-6602 0.00625 160

24

a

enhancement factor: = log (Kd/KD)

b

number of binding site on GNP: N=1/n (n: number of binding sites on lectin)

c

not detectable

In conclusion, an ITC-based method has been developed to quantitatively analyze
the binding affinity of glyconanoparticles with lectins. Thermodynamic parameters
including dissociation constant, entropy and enthalpy changes, and the number of
binding site were simultaneously determined by titrating GNPs into the lectin
solution. A 3-5 orders of magnitude affinity enhancement over the free ligand was
observed, which could be attributed to the multivalent ligand presentation on
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nanoparticles. The results were consistent with what have been obtained previously
using other analytical techniques such as fluorescence competition assays, dynamic
light scattering, and microarrays. In contract to these methods that either require a
label, or rely on indirect information, ITC is a direct measurement method that
gives the affinity constant, themodynamic parameters and stoichimetry of the
interactions. This technique provides a general and highly sensitive means to study
nanomaterial interactions with biological entities. The method developed will
benefit fundamental studies as well as the development of biosensors and
theranostic tools.
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Chapter 4. Impact of Ligand Presentation on the Binding Affinity of
Glyconanoparticles - Multivalency Effect

This work was published on “Wang, X.; Ramström, O.; Yan, M., Quantitative
analysis of Multivalent Ligands Presentation on Gold Glyconanoparticles and Their
Effects on Protein Binding. Anal. Chem. 2010, 82 (21), 9082-9089”
http://pubs.acs.org/doi/abs/10.1021/ac102114z
Reproduced by permission of American Chemical Society
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Introduction
A general feature of carbohydrate-protein interactions relates to their inherent
complexity, and multivalent ligand expression is frequently used to achieve
sufficiently high affinities required for sensitive recognition.68,69,190 In analogy to
ligand clustering at cell surfaces, nanomaterials can function as efficient nano-sized
scaffolds for multiple carbohydrate presentation. Strong binding enhancements
resulting from ligand presentation at the surfaces of nanomaterials have been
demonstrated in numerous studies.191-193 However, the current investigations are
generally short of in-depth characterization of the structures, compositions and
densities of the surface ligands, as well as the biological activities of the constructs,
since conventional surface analysis methods have been less optimized for
nanomaterials. Owing to the increasing interest in nanomaterials research, recent
development in spectroscopic and microscopic techniques has afforded detailed
structural and compositional information for nanomaterials.137,194,195 Nevertheless,
quantitative analysis of multivalent biological affinity at nanoparticle surfaces still
represents a considerable challenge. Furthermore, very limited methods were available
to measure the binding affinity of glyconanoparticles with proteins.11,196,197

In this chapter, we present detailed quantitative analyses on nanoparticle-based
multivalent carbohydrate-protein interactions. The effects resulting from the
nanoparticle size was investigated, and the ligand presentation with respect to ligand
density, surface environment, and linker spacer was studied. The well-established
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interaction system involving the lectin Con A, together with a panel of carbohydrate
species, was chosen as the target. This lectin is present as a tetramer at pH > 7, and
possesses specific affinities to -D-mannopyranoside, -D-glucopyranoside and their
derivatives.198,199 The system constitutes an excellent model for investigating the
multivalency effect,114 and studies on mannose–Con A interactions have established
that multivalent effects are highly sensitive to a range of factors, including the number
of binding sites, the ligand density, the structure of the ligand linkers, and the coupling
chemistry of the ligand attachments.200-203 In the present study, a recently developed
photochemical carbohydrate immobilization technique was adopted,154,181 and an array
of GNPs functionalized with different mono-, oligo-, and poly-saccharides were
prepared and ligand densities determined. A fluorescence-based ligand competition
assay was employed for the quantitative analysis of the binding affinities of the GNPs
where the apparent Kd values of the resulting GNPs were determined. The binding
affinity of GNPs with respect to the ligand density, spacer length, linker structure, as
well as the nanoparticle size was furthermore investigated.

Experimental details
Synthesis of PFPA-Thiols
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Figure 4.1 Synthesis of PFPA-thiols a-d.
3,6,9,12,37,40,43,46-Octaoxa-24,25-dithiaoctatetracontane-1,48-diylbis(4-azido2,3,5,6-tetrafluorobenzoate) (2a) (1-Mercaptoundec-11-yl)tetra(ethylene glycol) (1a,
100 mg, 0.26 mmol) in absolute ethanol (10 mL) was titrated with a saturated solution
of iodine in ethanol until the brown color of iodine persisted. The solution was
concentrated to 2 mL and then water (10 mL) was added. The solution was extracted
with diethyl ether (3 x 10 mL). The combined ethereal extracts were washed with
brine, dried over Na2SO4, and the solvent was removed under reduced pressure to
afford the disulfide as a brown oil. A solution of 4-azido-2,3,5,6-tetrafluorobenzoic
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acid129 (61.8 mg, 0.26 mmol) in CH2Cl2 (10 mL) was cooled to 0 ºC, and DMAP (3.7
mg, 0.03 mmol) and EDAC (57.5 mg, 0.3 mmol) were added. The disulfide obtained
above was then added, and the solution was stirred for 1 hour, after which the reaction
was allowed to warm up to room temperature and was stirred for 12 h under argon.
The product was recovered by extracting with CH2Cl2 and the organic layer was
washed with water, brine, and dried over Na2SO4. The crude product was purified by
column chromatography with 1:8 v/v hexanes/ethyl acetate to afford PFPA-disulfide
2a as a clear oil (57.1 mg, 37%). 1H NMR (400 MHz, CDCl3): δ (ppm) 4.52 (t, J = 3.2
Hz, 4H), 3.81 (t, J = 3.2 Hz, 4H), 3.66-3.54 (m, 24H), 3.46 (t, J =5.2 Hz, 4H), 2.67 (t,
J = 7.2 Hz, 4H), 1.61 (m, 4H), 1.57 (m, 4H), 1.28-1.23 (m, 28H).

13

C NMR (100

MHz, CDCl3): δ (ppm) 159.4, 145.4 (d, J = 260 Hz), 140.2 (d, J = 252 Hz), 127.9,
109.5, 70.4, 69.6, 69.1, 68.4, 61.3, 37.4, 36.7, 30.4, 30.1, 29.3, 29.2, 28.4, 28.0.
23-Mercapto-3,6,9,12-tetraoxatricosyl 4-azido-2,3,5,6-tetrafluorobenzoate (a).
To a solution of PFPA-disulfide 2a (40 mg, 0.033 mmol) in 1:1 v/v
ethanol/acetonitrile (20 mL), zinc dust (50 mg) and concentrated HCl (0.05 mL) were
added, and the reaction mixture was stirred under argon at room temperature for 1
hour. The reaction mixture was filtered, and the solvents were removed by rotary
evaporation. The residue was dissolved in chloroform, and the resulting solution was
washed twice with water followed by dilute NaHCO3 solution, and was dried over
Na2SO4. The crude product was purified by column chromatography with 1:8 v/v
hexanes/ethyl acetate to afford PFPA-thiol a as a clear oil (32.4 mg, 81%). 1H NMR
(400 MHz, CDCl3): δ (ppm) 4.40 (t, J = 2.8 Hz, 2H), 3.75 (t, J = 2.6 Hz, 2H), 3.6580

3.52 (m, 12H), 3.45 (t, J =5.6 Hz, 2H), 2.40 (q, J = 7.6 Hz, 2H), 1.67 (m, 4H) 1.271.23 (m, 15H). 13C NMR (100 MHz, CDCl3): δ (ppm) 159.1, 145.3 (d, J = 255 Hz),
140.4 (d, J = 252 Hz), 128.2, 108.9, 70.5, 69.9, 69.1, 68.5, 61.8, 37.7, 30.3, 29.7, 29.2,
28.7, 28.1, 23.4. IR (film) 2925, 2854, 2129, 1737, 1648, 1488, 1258, 1119, 998 cm-1.
HRMS (ESI) C26H39F4N3O6S [M+H]+ calcd 598.2574, found 598.2535.
11,11'-Disulfanediylbi(undecane-11,1-diyl)

bis(4-azido-2,3,5,6-tetrafluoroben-

zoate) (2b). Compound 2b was prepared following a previously reported procedure.181
11-Mercaptoundecyl 4-azido-2,3,5,6-tetrafluorobenzoate (b). Compound b was
synthesized from 2b following the same procedure as described above for a. 1H NMR
(400 MHz, CDCl3): δ (ppm) 4.36 (t, J =6.6 Hz, 2H), 2.52 (q, J = 7.6 Hz, 2H), 1.72 (m,
2H), 1.61 (m, 2H), 1.44-1.20 (m, 15H). 13C (100 MHz, CDCl3) δ (ppm) 159.5, 145.1
(d, J = 252 Hz), 140.2 (d, J = 256 Hz) 125.3, 108.1, 64.3, 36.1, 29.0, 28.1, 25.4, 23.7.
Anal. Calcd for C18H23F4N3O2S: C, 51.30; H, 5.50; N, 9.97. Found C, 51.36; H, 5.51;
N, 9.99.
6,6'-Disulfanediylbis(hexane-6,1-diyl) bis(4-azido-2,3,5,6-tetrafluoro-benzoate)
(2c). Compound 2c was synthesized from 1c following the same procedure as
described above for 2a. 1H NMR (400 MHz, CDCl3) δ (ppm) 4.37 (t, J = 6.4 Hz, 2H),
2.69 (t, J = 7.2 Hz, 2H), 1.81-1.65 (m, 4H), 1.53-1.38 (m, 4H). 13C NMR (100 MHz,
CDCl3): δ (ppm) 159.7, 145.1(d, J = 256 Hz), 140.5 (d, J = 258 Hz), 124.4, 107.2,
64.8, 39.1, 36.4, 29.1, 28.4, 23.1. Anal. Calcd for C26H24F8N6O4S2: C, 44.57; H, 3.45;
N, 12.00. Found C, 44.63; H, 3.50; N, 11.96.
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6-Mercaptohexyl 4-azido-2,3,5,6-tetrafluorobenzoate (c). Compound c was
synthesized from 2c following the same procedure as described above for a. 1H NMR
(400 MHz, CDCl3): δ (ppm) 4.32 (t, J = 6.4 Hz, 2H), 2.54 (q, J = 7.6 Hz, 2H), 1.75
(m, 2H), 1.64 (m, 2H), 1.45 (m, 4H), (t, J = 7.8 Hz, 1H).

13

C NMR (100 MHz,

CDCl3): δ (ppm) 159.3, 145.2 (d, J = 250 Hz), 140.4 (d, J = 266 Hz), 123.1, 108.1,
64.2, 36.1, 29.0, 28.1, 25.4, 23.7. Anal. Calcd for C13H13F4N3O2S: C, 44.44; H, 3.73;
N, 11.96. Found C, 44.31; H, 3.75; N, 12.04.
2,2'-Disulfanediylbis(ethane-2,1-diyl) bis(4-azido-2,3,5,6-tetrafluoro-benzoate)
(2d). Compound 2d was prepared following a previously reported procedure.204
2-Mercaptoethyl 4-azido-2,3,5,6-tetrafluorobenzoate (d). Compound d was
synthesized from 2d following the same procedure as described for a. 1H NMR (400
MHz, CDCl3): δ (ppm) 4.45 (t, J = 6.4 Hz, 2H), 2.86 (q, J = 7.2 Hz, 2H), 1.63 (t, J =
8.8 Hz, 1H);

13

C NMR (100 MHz, CDCl3): δ (ppm) 159.1, 145.3 (d, J = 258 Hz),

140.5 (d, J = 267 Hz), 123.7, 107.2, 64.0, 23.3. Anal. Calcd for C9H5F4N3O2S: C,
36.62; H, 1.71; N, 14.23. Found C, 36.25; H, 1.77; N, 14.02.

Preparation of carbohydrate-conjugated gold nanoparticles.
Citrate-protected Au NPs, ~22 nm in diameter, were prepared by adding sodium
citrate (1 wt%, 1.8 mL) to a boiling solution of HAuCl4 (0.25 mM, 100 mL) under
vigorous stirring, and the boiling was continued for an additional 5 min when the
solution became purple and finally light red.164 PFPA-thiol 3a-3d were synthesized
following the procedures in Figure 4.1. In a 250-mL flask, the Au NP solution
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prepared above (50 mL) was mixed with a solution of PFPA-thiol in ethanol (2.5 mM,
50 mL), and the resulting solution was stirred for 3 h. The solution was centrifuged at
10,000 rpm for 15 min, and the solid obtained was re-dispersed in ethanol (10 mL).
The centrifugation and re-dispersion process was repeated for 3 times to remove
excess PFPA-thiol, and the resulting PFPA-functionalized Au NPs was finally
dispersed in acetone (10 mL). The concentration of the Au NP solution, about 10 nM,
was determined by drying the sample under reduced pressure for 3 h and weighing.
The carbohydrate coupling was carried out following the procedure reported
previously.181 A solution of PFPA-functionalized Au NPs in acetone (10 mL) was
placed in a flat-bottomed dish, and an aqueous solution of carbohydrate (1 mM, 0.5
mL) was added. The mixture was covered with a 280-nm long-path optical filter (WG280, Schott Glass) and was irradiated with a 450-W medium pressure Hg lamp
(Hanovia) for 10 min under vigorous stirring. Centrifugation of the solution at 12,000
rpm for 15 min separated the carbohydrate-attached Au NPs as precipitates. Excess
carbohydrate was removed by membrane dialysis in water for 24 hours. Before
binding experiments, the nanoparticles were incubated in the pH 7.4 PBS buffer
solution containing 0.01% Tween 20 and 3% BSA for 30 min, centrifuged, and
incubated in a pH 7.4 PBS solution without BSA for further use.204

Determination of carbohydrate ligand density on GNPs.
A previously-developed colorimetry method was used to determine the ligand density
on Au NPs.181 Calibration curves were obtained for each carbohydrate where
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carbohydrate

solutions

of

various

concentrations

were

incubated

with

anthrone/sulfuric acid and the absorbances at 620 nm were measured. Carbohydrates
coupled on nanoparticles were subjected to the same assay where solutions of the
GNPs in Milli-Q water (30–50 g/0.5 mL) were treated with anthrone/H2SO4.
Background absorption due to Au NPs themselves was accounted for by treating
citrate-protected Au NPs solution of the same concentration with anthrone/H2SO4, and
the absorbance at 620 nm was subtracted from that of the GNPs. The amount of
surface-bound carbohydrate was then computed from the corresponding calibration
curve.

Preparation of GNPs of varied carbohydrate density.
Mixed thiol solutions were prepared from PFPA-thiol and 1-hexanethiol in ethanol,
with the mole percentage of PFPA-thiol varying from 10% to 98%. The
functionalization of Au NPs with mixed thiols followed the general functionalization
procedure described above, except that the pure thiol solution was replaced by the
mixed thiol solution when treating citrate-protected Au NPs. The subsequent
carbohydrate coupling was carried out following the same procedure described in
detail above.

Fluorescence competition binding assay.
AuNP-a-Man solutions of various concentrations (1 x10-8 – 5 nM) were prepared
from the stock solution (10 nM). The Con A-FITC solution (190 nM) was prepared in
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pH 7.4 PBS buffer containing MnCl2 (1 mM) and CaCl2 (1 mM). To the AuNP-aMan solution (1 mL) in a 1.5-mL microcentrifuge tube, D-mannose (1.44 mM, 0.1
mL) and Con A-FITC (0.1 mL) were added. The total volume of the final solution was
1.20 mL, where the concentration of D-mannose and Con A-FITC was 120

M and

16 nM, respectively. The solutions were shaken for 1 h, which was sufficient for
reaching equilibrium as shown in a time-based study, and centrifuged at 12,000 rpm
for 30 min where nanoparticles precipitated to the bottom of the tube. The
supernatants were transferred to a quartz cuvette for fluorescence measurements at 480
nm excitation, and the emissions at 517 nm were recorded using Felix32 software. The
incubation time was determined from a time study where GNPs were incubated with
Con A-FITC for varying amount of time. The fluorescence of the supernatant was
monitored, and after 1-hour incubation, the intensity no longer changed indicating that
the reaction had reached equilibrium. Measurement at each concentration was repeated
5 times, and the mean value of the emission intensities was used for the analysis. For
all other GNPs, the same procedure was followed except that the concentrations of the
GNPs were varied.

Results and Discussion
Synthesis of GNPs and ligand density determination.
GNPs were synthesized by coupling carbohydrate ligands to PFPA-functionalized Au
NPs. PFPA-thiol compounds of varying spacer lengths (a-d) (Figure 4.2) were
synthesized following the procedure shown in Figure 4.1. PFPA-thiols b-d contain
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varying lengths of methylene spacer linkage, whereas PFPA-thiol a has four ethylene
oxide (EO) in addition to the 11 methylene units. These PFPA-thiols were used to
investigate the impact of spacer linkage on the ligand density and binding affinity of
the corresponding GNPs.

Preparation of GNPs followed the photocoupling method developed previously
(Figure 4.2).181 Citrate-protected Au NPs were prepared from HAuCl4 and sodium
citrate. The size and uniformity were examined by DLS and TEM, which showed the
spherically-shaped Au NPs of 22 ± 2.6 nm in diameter. PFPA-thiols were then
introduced to the NP surface via a ligand-exchange reaction, and the presence of
PFPA on Au NPs was confirmed by 1H NMR and FTIR. Subsequent carbohydrate
immobilization was carried out by a photocoupling reaction, and the unattached
carbohydrates were removed by membrane dialysis. The resulting GNPs exhibited
excellent solubility in water. Furthermore, the centrifuged nanoparticle pellet was
easily dissolved in water, and the solution showed no change in the optical property.
The GNPs dispersed well in the PBS buffer and the solutions were stable for weeks at
4 °C.
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Figure 4.2 Functionalization of Au NPs with PFPA-thiol and subsequent coupling of
carbohydrates.

In order to quantitatively analyze GNPs–protein interactions, it is essential to
determine the carbohydrate ligand density. The anthrone-H2SO4 assay, a
colorimetric method that was widely used to measure carbohydrate concentrations
in solution205 and on solid surfaces133 was employed to measure the carbohydrate
ligand density on the GNPs.181 Calibration curves were obtained by treating
various concentrations of each carbohydrate with anthrone/sulfuric acid, and the
absorption at 620 nm was plotted against the carbohydrate concentration. Au NPs
with immobilized carbohydrate ligands were then subjected to the same assay, and
the amount of ligand on the nanoparticles was subsequently derived by comparing
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with the calibration curve. The coupling yield was estimated from the theoretically
calculated maximal amount of each ligand that can occupy the 22-nm Au NP
assuming a close-packed arrangement of the ligand on the NP. Table 4.1
summarizes the coupling yields of mono-, oligo- and poly-saccharides on Au NPs
functionalized with PFPA-thiol a. The results show that the coupling yield
increased with the size of the carbohydrate, which was anticipated since the
probability of attaching the ligand via CH insertion reactions increases with the
number of available CH bonds on the ligand.

Table 4.1 Coupling yield of mono-, oligo-, and poly-saccharides on Au NPs.
Carbohydrates

No. of Man/NP
(Theoretical)a

No of Man/NP
(Experimental)

Coupling Yield
(%)

Man

6333

3991

63 ± 4.2

Glc

6333

3641

57 ± 5.8

Man2

2303

1450

67 ± 6.1

Man3

1974

937

73 ± 5.4

Glc5

1299

836

79 ± 7.2

Dex

24

19

77 ± 16

a

Each data was the average of 5 samples.

Detection limit.
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The unique optical property of metal nanoparticles, plasmon resonance absorption,
offers a simple and attractive means to study molecular interactions with high
sensitivity.88,107 The binding events occurring at the surface of the Au NPs result in a
red shift in the plasmon resonance band, which can be conveniently monitored by UVvis spectroscopy.150 To determine the sensitivity of the GNPs in detecting lectins, Dmannose-coupled Au NPs were titrated with Con A, and the UV-vis spectra recorded
(Figure 4.3a). The absorbance at 650 nm vs. Con A concentration was then plotted
(Figure 4.3b), and the dynamic linear range of each curve was used to determine the
limit of detection (LOD), which was calculated to be 6.2 nM, 7.4 nM, 10 nM, and 22
nM for AuNP-a-Man, AuNP-b-Man, AuNP-c-Man and AuNP-d-Man, respectively.
The results showed that the sensitivity of the GNPs increased with the spacer length,
and the lowest LOD was obtained for GNPs prepared from PFPA-thiol a that contains
the long and flexible spacer linkage.

Figure 4.3 (a) UV-vis spectra of AuNP-a-Man upon addition of increasing
concentration of Con A. (b) Absorbance of GNPs at 650 nm vs. Con A concentration.
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Determination of binding affinity by fluorescence competition assay.
We developed a fluorescence competition assay to determine the binding affinity of
GNPs with lectins using a fluorescently-labeled lectin and a free competing ligand. In
a typical assay, GNPs of varying concentrations and a fixed concentration of a free
competing ligand were incubated with Con A-FITC (Figure 4.4a). Two equilibria, Con
A with GNPs and Con A with the free ligand, were established in the system (Figure
4.4b). Because a relatively low concentration of Con A was used, no agglomeration
was observed in the assay. After the solution was incubated for 1 hour, it was
centrifuged, bringing down GNPs including those bound to Con A-FITC. The
unbound Con A-FITC and free ligand-Con A conjugate remained in the supernatant,
corresponding to the amount of Con A-FITC that did not bind GNPs. The fluorescence
of the supernatant was measured (Figure 4.4d), and the intensity at 517 nm was plotted
as a function of the ligand density on GNPs (Figure 4.4e). From this concentration
response curve, the IC50 value was determined and the apparent dissociation constant
Kd was computed according to the Cheng-Prusoff equation206 (Figure 4.4c, Kd = Kd2).
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Figure 4.4 (a) The fluorescence-based competition binding assay; (b) two
equilibriums established in the system; (c) Cheng-Prusoff equation, where IC50 =
concentration of ligand displaying 50% of specific binding; [M] = concentration of
free ligand, Kd1 = dissociation constant of the free ligand with Con A; and Kd2 =
dissociation constant of GNPs with Con A; (d) fluorescence spectra of the supernatant
as a function of increasing concentration of AuNP-b-Man; (e) concentration response
curve, where the IC50 value was obtained.

This method was furthermore validated by several control experiments. First, different
concentrations of Con A-FITC, 18 nM, 40 nM and 80 nM, were used in the assay and
the binding affinity determined. The results obtained were similar for all three
91

concentrations with less than 5% variation among the three Kd values. Secondly,
different competing ligands, e.g., MeMan, Man2, and Man3, were used in addition to
Man. Although the binding affinities of these ligands with Con A were significantly
different from that of Man, when they were used as the competing ligand to determine
the Kd value of the same GNPs, the results were consistent and did not show
significant variations. Thirdly, AuNP-a-Man was incubated with Con A-FITC in the
absence of the competing ligand. In this case the fluorescence intensity decreased with
the concentration of Con A-FITC, and the typical IC50 concentration response curve
was not observed. Lastly, Au NPs coupled with Gal, a carbohydrate that does not bind
Con A, was tested to ensure that the binding was due to the specific interactions of the
surface-bound ligands with the lectin. No significant changes in the fluorescence
intensity were observed after varying concentrations of GNPs were incubated with
Con A-FITC, demonstrating that the strong affinity of AuNP-a-Man with Con A was
indeed due to the specific binding of surface-bound Man with Con A. This result
furthermore revealed that the non-specific adsorption of lectin to non-lectin binding
carbohydrates was minimal.

With the methodologies developed, we next tested the impact of nanoparticles as the
scaffold on the affinity ranking of various carbohydrate ligands with lectins. We chose
Man, Man2, and Man3, which have at least several-fold differences in binding affinity
between each ligand with Con A (Table 4.2). These ligands were attached to Au NPs
using PFPA-thiol 3a, and the apparent Kd values of the resulting GNPs with Con A
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were determined by the fluorescence competition assay. An increase in the binding
affinity of 4.5-fold and 33-fold was observed for AuNP-a-Man2 and AuNP-a-Man3
in comparison with AuNP-a-Man, respectively. Since the number of ligands on each
GNPs was different, when taking into consideration the ligand density, the affinity
increase was 12-fold and 141-fold, respectively. This compares well with the affinity
ranking of the corresponding free ligands, which was 20 and 158 times higher affinity
of Man2 and Man3 than Man with Con A in solution.136,148

In addition, the binding affinity of AuNP-a-Glc was determined, and the result
showed over 4 orders of magnitude higher affinity than that of the free ligand with
Con A (Table 4.2). Compared with the affinity enhancement in the case of Man,
however, the binding of AuNP-a-Man with Con A was over 30 times higher than that
of AuNP-a-Glc. Considering that the affinity of free Man with Con A was only 4
times higher than Glc, the affinity enhancement when the ligands were attached to
NPs was significantly higher. This observation, i.e., the amplification of binding
affinity difference due to multivalent interactions, has also been observed for
carbohydrate ligands on neoglycopolymers207 and dendrimers.208
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Table 4.2 Binding affinity of different GNPs with Con A

GNPs

Number of
ligands/NP

Kd (nM)

KD (M)a

AuNP-a-Man

3,991

0.43 ± 0.044

470209

AuNP-a-Man2

1,450

0.095 ± 0.008

24.0136

AuNP-a-Man3

937

0.013 ±0.002

2.97136

AuNP-a-Glc

3,641

12.7 ± 2.5

1,786209

a

KD: dissociation constant of the corresponding free ligand with Con A.

Binding affinity with respect to ligand presentation.
Unlike the free ligand that has the translational and rotational freedom in solution, the
surface-bound ligand is no longer an un-restricted entity. Each ligand becomes a
member of the nanomaterial carrier and can act cooperatively when interacting with
their binding partners. The binding affinity is sensitive to a number of factors
including the coupling chemistry, the size of the nanomaterial scaffold, the type and
length of the spacer linkage connecting the ligand and the nanomaterial, the
flexibility/rigidity of the spacer, the density of ligands and the distance between them.
In the present study, the ligand density, linker length, and nanoparticle size were
varied, and their impacts on the binding affinities of the resulting GNPs were
investigated.
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Ligand density. To control the surface ligand density, we employed the mixed SAM
approach where a non-photoactive thiol together with PFPA-thiol was used to
functionalize Au NPs. Solutions containing PFPA-thiol a or b and 1-hexanethiol at
varying mole ratios were used to treat Au NPs. Man was subsequently coupled and the
density of attached ligand measured (Table 4.3). The apparent Kd value of the
resulting GNPs was then determined using the fluorescence competition assay
described above. Results showed that the binding affinity generally increased with the
ligand density. For AuNP-a-Man, however, there seems to be a maximal affinity for
Au NPs treated with 98% PFPA-thiol a at the ligand density of 3,004 Man/NP. This
maximal affinity was not observed in the case of AuNP-b-Man, likely due to the
lower ligand density even at 100% PFPA-thiol treatment (2,824 Man/NP). To
investigate the generality of this observation, Man2 and Man3 were coupled on Au
NPs treated with mixed SAM of 1-hexanethiol and PFPA-thiol a, and the Kd values
were measured with respect to the ligand density. The highest binding affinity of the
resulting GNPs occurred at 50% and 30% of PFPA-thiol a in the mixed SAM,
corresponding to the ligand density of 289 Man2/NP and 132 Man3/NP, respectively
(Figure 4.5).
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Table 4.3 Binding affinity as a function of ligand density.
PFPA-

AuNP-a-Man
Kd (nM)a

AuNP-b-Man
Kd (nM)a

thiol

Number of

(mole%)

Man/NP

10%

107

27.4 ± 2.3

99

92 ± 12

30%

283

8.67 ± 0.87

260

16.1 ± 5.5

50%

544

1.93 ± 0.25

549

12.3 ± 4.1

70%

1,444

1.33 ± 0.31

1,196

10.8 ± 1.8

90%

2,275

1.01 ± 0.22

1,726

9.6 ± 3.0

95%

2,756

0.88 ± 0.14

2,090

7.1 ± 1.7

98%

3,004

0.39 ± 0.09

2,474

5.0 ± 1.0

100%

3,991

0.43 ± 0.044

2,824

4.0 ± 0.7

Number of
Man/NP

a

Each data was the average of 3 measurements each on 5 samples.
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Figure 4.5. Binding affinity vs. ligand density for Man (a), Man2 (b), and Man3 (c)
with Con A. Each data point was the average of 3 measurements each on 5 samples.

A few general observations can be drawn from the ligand density studies. For all three
ligands, there was a sudden increase in binding affinity, and after which, the Kd values
remained more or less constant. The ligand density at which the drastic change in
binding affinity occurred was estimated from the intercept of the two relatively linear
curves in each graph, which was 370 Man/NP, 166 Man2/NP and 138 Man3/NP,
respectively. Assuming that the ligands were evenly distributed on the GNPs, the
footprint occupied by each ligand on the nanoparticle surface was calculated to be 4.1
nm2, 9.2 nm2 and 11.0 nm2, and the distance between neighboring ligands were
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approximately 2.0 nm, 3.0 nm and 3.3 nm for Man, Man2 and Man3, respectively (see
detailed calculation in Supporting Information). Note that the distance between each
binding site on Con A is 6.5 nm as determined by X-ray structural analysis.183 This
distance is larger than the ligand spacing on NPs indicating that the binding is not
monovalent and the higher ligand density is necessary for the enhanced affinity. The
internal diffusion mechanism, which states that a lectin molecule “binds and jumps”
from ligand to ligand along the scaffold,190 can be applied to explain the results.
According to the mechanism, the more ligands there are on the scaffold, the longer the
dwelling time of the lectin on the ligands, and the slower the lectin would dissociate.
This affinity increase was observed for all three ligands where the Kd values decreased
drastically at lower ligand density (Figure 4.5). The affinity started to decrease after
the maximal affinity was reached, and this decrease in affinity was more pronounced
as the size of the ligand increased. This was likely due to the steric effect where the
larger ligand hinders the lectin binding.210

Spacer. PFPA-thiols a, b, c and d were used as the coupling agent to evaluate the
effect of spacer linker on the binding affinity of the resulting GNPs. PFPA-thiols c, d
contain a shorter spacer of six and two methylene units, and the Kd values of the
corresponding GNPs were 15 nM and 19 nM, respectively (Table 4.4). When Au NPs
were functionalized with PFPA-thiol b having 11 methylene units, Kd decreased to 4.0
nM, which represents 4-5 times increase in binding affinity as compared to the shorter
spacer c and d. When PFPA-thiol a was used, the binding affinity increased an
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additional order of magnitude in comparison to PFPA-thiol b. Because the ligand
density increases with the spacer length, it could also contribute to the observed
enhancement in the binding affinity. However, the density increase alone could not
account for the magnitude of the affinity enhancement. At the similar ligand density,
for example, 544 and 549 Man/NP for AuNP-a-Man and AuNP-b-Man, respectively,
the binding affinity was 6 times higher for AuNP-a-Man than AuNP-b-Man (Table
4.4). This affinity increase was therefore solely caused by the difference in the spacer
linkage between the two GNPs. In order to quantitatively assess the binding affinity
enhancement of different GNPs, an affinity enhancement factor (EF) was used, as
defined in Eq. 4.1,
EF = KD/[Kd x N]

(4.1)

where KD is the dissociation constant of free ligand with Con A, which is 470 M for
Man,209 Kd is the apparent dissociation constant of GNPs with Con A, and N is the
number of ligands on each GNP. Here, the ligand density is taken into consideration,
and the EF value can therefore be used to rank binding affinity with respect to the
difference in the spacer linkage. Results in Table 4.4 show that the EF values for
AuNP-d-Man and AuNP-c-Man were similar, ~16, whereas that of AuNP-b-Man
was 2.6 times higher at 42, and that of AuNP-a-Man was in addition 17 times higher
at 274. These results clearly demonstrate that longer spacers led to enhanced binding
affinity of GNPs with lectins. The spacer elevates the ligand further from the solid
substrates. On curved surfaces such as nanoparticles, a longer spacer would also result
in a larger distance between the ligands at the same ligand density. Both events would
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Table 4.4 Binding affinity of GNPs with Con A.
GNPs

Number of Man/NP

Kd (nM)a

EF

AuNP-a-Man

3,991

0.43 ± 0.044

274

AuNP-b-Man

2,824

4.0 ± 0.72

42

AuNP-c-Man

1,959

15 ± 2.0

16

AuNP-d-Man

1,590

19 ± 2.2

16

a

Each data was the average of 5 samples, 3 measurements each.

reduce the steric hindrance when the lectin approaches the ligands, making the ligands
more accessible for interacting with the lectin.

Nanoparticle size. It is well-established that the physical and chemical absorption, and
the catalytic property of gold nanoparticles are highly size-dependent.171-173 In this
study, the effect of nanoparticle size on binding affinity was investigated by varying
the diameter of Au NPs. In addition to the 22-nm nanoparticles, Au NPs of 7 nm, 14
nm, and 30 nm in diameter were synthesized using the same protocol (Figures 4.6),
and Man was subsequently conjugated using PFPA-thiol b. The ligand densities of the
resulting GNPs and their binding affinities were measured (Table 4.5). As expected,
the number of ligands attached on Au NPs increased with the size of the nanoparticles.
The binding affinity of GNPs with particle sizes of 7 nm, 14 nm, and 22 nm were
similar, whereas a decrease of about 6-fold in binding affinity was observed for the
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30-nm GNPs. The EF values calculated for each GNPs showed a considerable sizedependent effect, with the EF value increasing with decreasing particle size. Smaller
nanoparticles yielded the highest affinity enhancement, likely due to their large
surface-to-volume ratio and higher mobility in solution.

Figure 4.6 TEM images of gold nanoparticles in 4 different sizes: 7 nm (a), 14 nm (b),
22 nm (c) and 30 nm (d).
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Table 4.5 Binding affinity of GNPs of varying sizes
Au NP Diameter

Number of Man/NP

Kd (nM)

EF

7.2 ± 1.8

297

3.38 ± 0. 67

468

14 ± 2.6

1,127

3.14 ± 0.49

132

22 ± 3.3

2,824

3.99 ± 0. 81

42

30 ± 4.0

4,486

24.8 ± 3.1

4.2

(nm)

Conclusion
In conclusion, we developed a fluorescence-based competition assay to determine the
apparent dissociation constants of GNPs with lectin. The assay was successfully used
to determine the Kd values and to evaluate the binding affinity of GNPs. When
carbohydrate ligands were attached on the Au NP scaffold, their interactions with
lectins were drastically enhanced, and several orders of magnitude increases in
binding affinity were observed between GNPs and lectin. Systematic studies were
conducted to investigate the impacts of nanoparticle size, spacer length, ligand size
and density on the binding affinity of GNPs. Results show that the lectin binding to
ligands on GNPs is profoundly affected by how the ligands are displayed on the NP
surface. Findings from this study are important that GNPs with controlled binding
affinity can be readily synthesized by varying ligand density, spacer linker, and
scaffold configuration. This will open up immense opportunities for tailor-made
glyconanomaterials where the ligand display can be exploited to tune their
bioaffinities.
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Supporting Information
Calculations of ligand density and distance

Figure 4.7 Schematic illustration of Con A and GNP.
Assuming that carbohydrate occupies in space by taking the shape of a square, the
ligand molecule is then projected to the surface using Chem 3D (CambridgeSoft,
Ultra, version 9.0), and the surface area of each Man, Man2 and Man3 molecule were
calculated to be 0.24, 0.66, and 0.77 nm2, respectively.
The ligand-ligand distance (L) can be calculated from the following:

L=

SNP
N
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where SNP is the surface area of Au NP, and N is the number of ligands attached. At
the point where there was a sudden increase in binding affinity, the number of ligands
was determined from the intercept of the two relatively linear curves of each graph
which was 370, 166 and 138 ligands per NP for Man, Man2, and Man3, respectively.
Therefore, the ligand distance at the deflection point is 2.0, 3.0 and 3.3 nm for Man,
Man2 and Man3, respectively.

104

Chapter 5. Applications of Glyconanomaterials in Bioanalysis

The work in Section 5.1 was published on “Wang, X.; Matei, E.; Deng, L. Q.;
Ramström, O.; Gronenborn, A. M.; Yan, M., Multivalent Glyconanoparticles with
Enhanced Affinity to Anti-Viral Lectin Cyanovirin-N Chem. Commun. 2011, 47,
8620-8622”
http://pubs.rsc.org/en/Content/ArticleLanding/2011/CC/C1CC12981C
Reproduced by permission of The Royal Society of Chemistry

The work in Section 5.2 was published on “Wang, X.; Ramström, O.; Yan, M., Dyedoped silica nanoparticles as efficient labels for glycans. Chem. Commun. 2011, 47
(14), 4261-4263” (Section 3.2)
http://pubs.rsc.org/en/Content/ArticleLanding/2011/CC/c0cc05299j
Reproduced by permission of The Royal Society of Chemistry

The work in Section 5.3 was submitted for publication.
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5.1 Signal Enhancement Study Glycan-lectin Interactions using Anti-HIV Lectins

In this chapter, a specific platform was presented for the binding signal enhancement
of glyconanoparticle with biologically important anti-HIV lectin Cyanovirin-N in a
rigorous and coherent way. Our method enables sensitive recognition of different type
of lectin mutants with various binding sites using high-mannose conjugated gold
nanoparticles, and more significantly visualize the difference using UV-vis and TEM
techniques. No other known methods can efficiently accomplish this. This fact alone
results in a platform, where the effect of ligand display on multivalency can be
efficiently monitored, as well as quantitatively analyzed. The present coupling method
is novel, using only unprotected high mannose oligosaccharides structures. We have
demonstrated that our method is general, versatile, and has been validated with other
solution- and surface-based assays. It is of high importance that our results have
shown that the glyconanoparticles system is highly valid in distinguishing
multivalency effects based on nanoparticle presentation. The binding affinities of both
Man2 and Man3-conjugated nanoparticles were found several orders of magnitude
higher than those of free Man2 and Man3 in solution, based on ITC results.

Lectins, carbohydrate-binding proteins, play critical roles in a plethora of biological
processes.[1] An in-depth understanding of carbohydrate-lectin interactions is not only
fundamentally important for elucidating their biological functions, but also of
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outstanding practical value in the design and development of therapeutics and
diagnostic tools. Cyanovirin-N is an 11 kDa cyanobacterial lectin that exhibits
inhibitory activity against a number of viruses, including HIV, at concentrations as
low as nanomolar. Its anti-HIV activity is mediated by binding to the high-mannose
(HM) structures on the envelope glycoprotein gp120.[2] Previous studies established
that the binding epitope(s) on N-linked high oligomannosides for CV-N comprised αD-Manp-(1→2)-α-D-Manp

moieties on the glycan’s D1 and D3 arms.[3]

Multivalency, resulting in cooperative interactions of multiple ligands with multiple
receptors, is a general phenomenon that occurs in many biological processes involving
molecular recognition. Multivalent interactions are often significantly stronger than
the corresponding monovalent interactions, and, as such, the design and creation of
multivalent reagents is an important strategy for generating diagnostic and therapeutic
tools.[4] In glycobiology, these kinds of approaches are especially relevant given the
commonly observed weak affinities between glycans and lectins.[5] On the other hand,
high glycan structures exhibit drastically enhanced apparent affinities, compared to the
monovalent ligands. However, the synthesis of high glycans is tremendously
demanding, involving multiple protection/ deprotection steps and complex
stereochemistry control. As such, their availability is limited. An alternative approach
for creating multivalency is to use a scaffold, such as polymers, lipids or
nanomaterials, on which multiple copies of a ligand can be presented, thereby
generating a multivalent ligand.[6] For example, Melander and coworkers prepared
small molecule-coated gold nanoparticles (AuNPs) as effective inhibitors for HIV
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fusion,[7] and Gervay-Hague’s group reported that galactosyl- and glucosylfunctionalized AuNPs exhibited 300 times better binding to gp120.[8] In previous
studies from our group, we showed that carbohydrate ligands conjugated to AuNPs
exhibited affinities up to five orders of magnitude higher than those of the
corresponding monomeric ligands with lectins.[9]
Here, we conjugated two low-mannoses, Man2 and Man3, to the AuNP scaffold, and
investigated the binding affinity of the resulting GNPs with CV-N lectins (Figure 5.1).
In order to derive quantitative numbers for the affinity enhancement caused by
AuNPs, we developed a fluorescence competition assay and determined the apparent
dissociation constant of GNP binding to CV-N (KD). The results from this assay were
compared with the Kd values of monomeric glycan binding to CV-N using isothermal
titration calorimetry (ITC).

Experimental Section
Preparation of gold glyconanoparticles
AuNPs, 22 nm in diameter, were prepared and functionalized with PFPA-disulfide
following the same procedure as described in a previous chapter.[9] The subsequent
carbohydrate coupling was carried out photochemically as reported previously.[10].
Before the binding experiments, the GNPs were incubated in 20 mM sodium
phosphate buffer solution (pH 6.0), containing 0.01% NaN3, 0.01% Tween 20 and 3%
BSA for 1 hour, centrifuged, and placed in buffer without BSA until further use.
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CVN binding assays
GNP-M3 (5 nM, 1.0 mL) was incubated in a solution of CVNQ50C or CVNMutDB in 20
mM sodium phosphate buffer solution (10 M, 1.0 mL), pH 6.0, containing 0.01%
NaN3 for 1 hour with constant shaking. UV-vis spectra of the resulting solutions were
recorded on a Perkin Elmer Lambda 45 UV-vis spectrophotometer, and each
measurement was performed at least 3 times.

Isothermal Titration Calorimetry (ITC)
ITC experiments of Man3 binding to CVN were performed using an ITC200
Microcalorimeter from Microcal, LLC. (Northampton, MA) in 50 mM sodium
phosphate buffer, pH 7.5, 200mM NaCl, 0.02% NaN3. The concentration of CV-N
was 50 M, and that of Man3 was 0.64 mM. In each individual experiment, ~38 L of
Man3 was injected through the computer-controlled 40-L micro-syringe at an
interval of 4 min into the protein solution in the same buffer (cell volume = 200 L)
while stirring at 350 rpm. Calorimetric titrations of Man2 binding to CVN were
performed using a VP-ITC isothermal titration calorimeter (MicroCal, LLC;
Northampton, MA). Titrations were carried out at 30oC in the same buffer as described
above for Man3. A 35 M CV-N solution was placed in the calorimeter cell (~1.44
mL active volume), stirred at 310 rpm, and 9-L aliquots of 1.5 mM Man2 solution
were added at 2 min intervals from a 295-L stirring syringe. A total of 30 injections
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were performed. The experimental data were fitted to a theoretical titration curve
using the software supplied by MicroCal. A standard two-site model was used with
ΔH (enthalpy change, in kcal/mol), Ka (association constant, in M-1), and N (number
of binding sites) as the variables.

Fluorescence competition binding assays
The previously reported protocol was adapted,[9] as described below. A series of GNPM2 solutions were prepared by diluting a stock solution (10 nM) to concentrations
between 5 nM and 1 x10-8 nM. A stock solution of Cy5-CVN (1.20 M) was prepared
in pH 6.0 sodium phosphate buffer (20 mM). To a solution of GNP-M2 (1 mL) in a
1.5-mL microcentrifuge tube, Man2 (0.48 mM, 0.1 mL) and Cy5-CVN (1.2 M, 0.1
mL) were added. The total volume of the final solution was 1.20 mL, and the
concentrations of Man2 and Cy5-CVN were 40 M and 100 nM, respectively. The
solutions were shaken for 1 hour, and then centrifuged at 12,000 rpm for 30 min until
all nanoparticles were completely pelleted at the bottom of the tube. The supernatants
were taken out for fluorescence measurement using a PTI spectrofluorimeter (Photon
Technology International). Excitation was at 649 nm and emission was recorded at
666 nm for analysis. The same procedure was followed for GNP-M3, except that
Man3 was used as the competing ligand. Measurement for each concentration was
repeated 5 times, and values were averaged.
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KD1 and KD2, apparent dissociation constants for GNP binding to the glycan-binding
site on Domain A and Domain B of CVNQ50C, respectively, were obtained from bestfitting the response curves, using a two-site competitive binding model with the
equation in KaleidaGraph software.

Figure 5.1 Synthesis of Man2- and Man3-conjugated AuNPs GNP-M2 and GNP-M3.

Results and discussion
GNP-M2 and GNP-M3 were prepared following a previously established
procedure,[10] outlined in Figure 5.1. Uniform, ~22 nm AuNPs were synthesized by the
Turkevich method[11] and were subsequently functionalized with PFPA-disulfide
(Figure 5.1). Man2 and Man3 were then conjugated to the PFPA-functionalized
AuNPs using a photocoupling method[10] by way of a CH insertion reaction of the
photogenerated perfluorophenylnitrene.[12] The ligand density was determined using a
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colorimetric approach with anthrone/sulfuric acid. Values of 1,516 ± 232 Man2 and
1,037 ± 148 Man3 were obtained for GNP-M2 and GNP-M3, respectively.
Binding affinities of GNP-M3 to CV-N was evaluated using two CV-N variants:
CVNMutDB and CVNQ50C. CVNQ50C is essentially a wild-type variant, comprising two
separate glycan binding sites one on Domain A and one on Domain B.[3a, 3c] Domain A
exhibits a slight preference for the Man3 units and domain B for the Man2 units.[13, 3c]
The Cys substitution at position 50 was introduced to allow for specific fluorescence
labeling of CV-N without interfering with glycan binding. In the CVNMutDB variant on
the other hand, the glycan binding site on domain B is completely eliminated, while
the site on domain A still can bind glycan ligands. Since this variant no longer can
cross-link glycans on gp120, it has lost its anti-HIV activity.[14] Therefore, in
interactions with GNPs, we would expect that CVNQ50C can act as a crosslinker and
form a complex with GNP-M3, while no such crosslinking should be possible
between GNP-M3 and CVNMutDB. Indeed, GNP-M3 treatment with CVNQ50C caused
a red shift from 529 nm to 542 nm in the surface plasmon resonance (SPR) band of
AuNPs (Figure 5.2a), indicative of particle size growth.[15] Such an increase in particle
size was further confirmed by TEM which revealed the presence of clusters of
aggregated particles (Figure 5.2c). When GNP-M3 was treated with CVNMutDB,
however, no SPR shift was observed (Figure 5.2b). TEM images were devoid of
aggregates and only isolated single particles were observed in this case (Figure 5.2c).
Dynamic light scattering (DLS) measurements of CV-N treated GNP-M3 particles
yielded average particle sizes of 25.9 ± 3.5 nm and 38.3 ± 4.6 nm for CVNMutDB and
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CVNQ50C, respectively. These results are all consistent with our previous structural
studies on CVNMutDB that revealed a single glycan binding site.[14]

Figure 5.2 UV-vis spectra of GNP-M3 before (solid line) and after (dotted line)
treatment with a) CVNQ50C and b) CVNMutDB. TEM micrographs of GNP-M3 treated
with c) CVNQ50C and d) CVNMutDB. Scale bars: 100 nm.

The binding affinities of the GNPs to the CV-N variants were evaluated using a
recently developed fluorescence-based competition assay.[9] In the experiment, free
ligand competitor (Man2 for GNP-M2, Man3 for GNP-M3) together with varying
concentrations of GNP-M2 or GNP-M3 was incubated at a fixed concentration of
Cy5-CVNQ50C, specifically Cy5-labeled CVNQ50C (Figure 5.3a, see experimental
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section for details). The solution was centrifuged to remove all GNPs and the
fluorescence intensity of the supernatant was measured. The difference in fluorescence
intensity of Cy5-CVNQ50C before and after incubation with GNPs corresponds to the
amount of the bound CVNQ50C. Concentration response curves for GNP-M2 or GNPM3 permit the determination of IC50 values (Figure 5.3c).

Figure 5.3 Fluorescence competition assay. a) Schematic representation of binding
scenario. b) Modified Cheng-Prusoff equation based on a competitive two site binding
model, where [M] is the concentration of the free ligand, and Kd1 and Kd2 are the
dissociation constants of the free ligand for the glycan-binding sites on Domains A
and B of CVNQ50C, respectively. The data were fitted using the maximum bound
fractions, fBmax1 and fBmax2, corresponding to the two binding sites, and dissociation
constants KD1 and KD2 as adjustable parameters. c) Concentration response curves of
GNP-M2 and GNP-M3.
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In order to extract the binding constants of GNPs with CVNQ50C, it is necessary to
know the Kd values of the monomeric ligands, Man2 and Man3, with CVNQ50C . These
values were determined by ITC and the dissociation constants, Kd1 (glycan-binding
site on Domain A) and Kd2 (glycan-binding site on Domain B), were calculated based
on a two-site binding model (see Figure 5.4). Values for Kd1 and Kd2 of 700 M and
64 M for Man2, and 3.4 M and 43 M for Man3, respectively, were calculated
(Table 5.1). These values agree well with our previous observation that slightly
stronger binding of Man2 to the site on Domain B than to that on Domain A occurs,
while the opposite is true for Man3.[3a, 3c, 14] These data, together with the IC50 values
determined from the data shown in Figure 5.3c, were then used to calculate the
apparent dissociation constants for the site on Domain B, KD1 and KD2, based on a two
binding site model (Figure 5.3b).
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Figure 5.4 Calorimetric titration of a) CVNQ50C (35 M) with Man2 (1.5 mM), and b)
CVNQ50C (50 M) with Man3 (0.64 mM) at 30 oC. The raw data were obtained for 30
and 20 automatic injections, respectively. The integrated curves show experimental
points (■) and the best fit (-). The buffer was 50 mM sodium phosphate, 200 mM
NaCl, pH 7.5, containing 0.02% NaN3.

The data summarized in Table 5.1 demonstrate that both GNPs, GNP-M2 and GNPM3, exhibit an affinity enhancement by several orders of magnitude compared to the
affinities measured for the isolated, monomeric sugars interacting with CVNQ50C.
Taking into account the number of ligands on the particles, i.e. considering the
affinity/ligand, an increase up to several hundred times is still present for the AuNPbound glycan (Table 5.1). In addition, GNP-M3 exhibited a higher affinity than
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Table 5.1 Affinities for Man2/3 (Kd) and GNP-M2/3 (KD) binding to CVNQ50C.
Numbers in parentheses correspond to EF (=Kd1/KD1•Number of ligands on GNP).
Kd1 or KD1

Kd2 or KD2

(Domain A)

(Domain B)

Man2

700 ±50 M

64 ± 4 M

GNP-M2

56.4 ± 7 nM (8.2)

0.24 ± 0.1 nM (176)

Man3

3.4 ± 0.2 M

43 ± 2 M

GNP-M3

0.011 ± 0.007 nM (309)

11.8 ± 2.3 nM (3.6)

Ligand

GNP-M2 for both domains. These results correlate well with the general affinity
ranking of the free ligands Man2 and Man3, and are consistent with observations in
our previous study with a different GNP-lectin system.[9] Interestingly, for both GNPM2 and GNP-M3, the affinity enhancement is more pronounced for the better binding
domain. For example, Man2 exhibits a higher affinity for the binding site on Domain
B, and with GNP-M2, the affinity enhancement factor (EF) is 178 for the Domain B
site vs. 8.3 for the Domain A site (Table 5.1). For GNP-M3, on the other hand, the
opposite was observed that the EF is higher for the Domain A site (340) than for the
Domain B site (3.8).

Conclusion
In conclusion, we have successfully grafted low-mannose ligands onto AuNPs via an
efficient photocoupling reaction. The resulting GNPs interacted with the CV-N
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variants CVNMutDB and CVNQ50C in a manner that is consistent with the expected
behavior of one- and two-site binders. Crosslinked complexes and aggregates were
observed when GNP-M3 was treated with the two-site CVNQ50C while only single
particles were seen after treatment with the single-site variant CVNMutDB. Furthermore,
these GNPs exhibited significantly higher affinity towards the CV-N lectins, compared
to the free glycan ligands, demonstrating that AuNPs serve as an efficient multivalent
scaffold that significantly enhances the apparent affinity. This affinity enhancement
compares well with that of other synthetic multivalent ligands. Therefore, a general
strategy can be envisioned which uses simple glycans, rather than large and complex
sugars, for grafting onto a multivalent scaffold for affinity amplification. These types
of approaches will aid in development of effective new glyconanomaterials for
diagnostic and therapeutic applications.
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5.2 Labeling Native Glycans with Dye-doped Silica Nanoparticles

Introduction
A major challenge in bioanalysis, including high-throughput screening, is the
means to effectively display the outcome of the ligand-receptor interactions.
Fluorescence is by far the most commonly used detection method, which requires
the conjugation of a fluorescent tag to the ligand to be studied.211-213 Among the
fluorescent tags, organic dyes continue to be the label of choice due to the
availability of a wide variety of commercial products of diverse structures,
functionalities, solubility, and spectral properties. A major drawback of organic
dyes, however, is their relatively poor photostability. When exposed to light,
organic dyes can photobleach and lead to a decrease in fluorescence intensity. A
clever solution to this problem is to entrap the fluorescent dye inside a solid
matrix, for example silica nanoparticles.214 The nanoparticle protects the dye
molecules from being directly exposed to the environmental oxygen, and thus
greatly enhances the photostability of the entrapped dye.215 Furthermore, because a
large number of dye molecules can be embedded inside a nanoparticle, high
fluorescence emission can be obtained, the intensity of which exceeds the dye
molecule itself or even quantum dots.216-219 In addition, silica nanoparticles are
biocompatible and of low toxicity.3,84 Uniformly sized silica nanoparticles can be
readily prepared from inexpensive starting materials following simple synthetic
procedures.162
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Ligand labeling often requires a robust conjugation method where the labeling
agent can be covalently attached to the ligand. For many biomolecules, this can be
conveniently accomplished, for example, by using a commercial kit containing
chemically-derivatized labeling agents. For ligands that lack functional groups or
are difficult to derivatize, the task of labeling can be complex and challenging. We
have developed a general coupling chemistry, based on perfluorophenyl azides
(PFPAs), that can conjugate a variety of molecules regardless of their chemical
structures.126,140,181,220 Upon photochemical or thermal activation, PFPA is
converted to a highly reactive singlet perfluorophenylnitrene which form covalent
adducts with neighboring molecules by way of CH insertion and/or C=C addition
reactions. Therefore, by functionalizing FSNPs with PFPA, ligands can be
conjugated to FSNPs via the photocoupling reaction of the surface PFPA. In this
study, we present that PFPA-functionalized FSNPs can be used as highly efficient
fluorescence labels for carbohydrate ligands. Carbohydrates are an important class
of biomolecules involved in many important biorecognition processes including,
for

example,

cell

communication,

immune

responses,

fertilization,

and

infections.57,61,64,178 Studies of these processes are, however, hampered by the high
complexity of glycan structures and the lack of efficient bioanalytical tools.74,221-223
The present study seeks to address some of these challenges by developing a new
method to efficiently label underivatized carbohydrates with FSNPs. We evaluate
FSNP-labeled carbohydrates for their affinities with lectins. The synthesized glyco
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FSNPs are furthermore applied to image bacteria, and to probe carbohydrateprotein interactions on a lectin microarray.

Experimental details
Synthesis of FITC-doped silica nanoparticles FSNPs.
Fluorescein isothiocyanate (39 mg, 0.10 mmol) was mixed with APTMS (23 L, 0.10
mmol) in 100 mL of absolute ethanol, and was stirred at 42 oC for 24 h to yield the
FITC-silane precursor as a bright yellow solution. The fluorescent nanoparticles were
synthesized following a modified protocol from the classic Stöber protocol,162 similar
to what was previously described.125 The dye precursor solution (5 mL) was mixed
with TEOS (2.8 mL), and the mixture was added to 200 proof absolute ethanol (34
mL) followed by NH4OH (35%, 2.8 mL). The reaction was allowed to proceed at
room temperature for at least 8 h with vigorous stirring to yield a bright yellow
colloidal solution. The particle diameters were determined by TEM and DLS (Figure
5.9 and 5.10 in Supporting Information)

Functionalization of silica nanoparticles with PFPA.
PFPA-silane (80 mg), synthesized following a previously reported procedure,123 was
added directly to the Stöber solution prepared above, and the mixture was stirred at
room temperature overnight. The next day the mixture was brought to reflux while
continuing stirring for 1 h at ∼78 oC to facilitate the covalent bond formation between
PFPA-silane and the silica nanoparticles.125 The mixture was centrifuged at 8,000 rpm
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for 10 min, and the precipitate was redispersed in the fresh solvent by sonication. This
centrifugation/redispersion procedure was repeated three times with ethanol and twice
with acetone.

Conjugation of carbohydrates onto FSNPs.
Our previous reported procedure of coupling carbohydrates on gold nanoparticles was
followed.181 The solution of PFPA-functionalized FSNPs in acetone (20 mg/mL, 5
mL) was placed in a flat-bottom dish, and an aqueous solution of carbohydrate (10
mg/mL, 1 mL) was added. The mixture was covered with a 280-nm long-path optical
filter (WG-280, Schott Glass) and was irradiated with a 450-W medium pressure Hg
lamp (Hanovia) for 10 min under vigorous stirring. Centrifugation of the solution at
8,000 rpm for 10 min separated the carbohydrate-attached FSNPs as precipitates.
Excess carbohydrate was removed by membrane dialysis in water for 24 hours. The
concentration of FSNP, ~17.2 mg/mL, was determined by drying the solution under
reduced pressure for 3 hours and weighing.

Determination of carbohydrate density on glyco-FSNPs.
A previously developed colorimetric method was followed to determine the density of
carbohydrates immobilized on FSNPs.181 Calibration curves were first obtained for
each carbohydrate where carbohydrate solutions of various concentrations were
incubated with anthrone/sulfuric acid and the absorbances at 620 nm were
measured.155 A freshly-prepared anthrone solution in concentrated H2SO4 (0.5 wt%, 1
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mL) was added to a carbohydrate solution in water (0.5 mL) in an ice bath under
stirring. The solution was then heated to 100 oC and stirred for 10 min. After cooled to
room temperature, the UV-vis spectra of the resulting solutions were recorded on a
Perkin-Elmer Lambda 45 UV-vis spectrometer.
Carbohydrates coupled on nanoparticles were subjected to the same assay where
solutions of the glyco-FSNPs in Milli-Q water (30–50 g/0.5 mL) were treated with
anthrone/H2SO4. Background absorption due to FSNPs themselves was accounted for
by treating FSNPs solution of the same concentration with anthrone/H2SO4, and the
absorbance at 620 nm was subtracted from that of the glyco-FSNPs. The amount of
surface-bound carbohydrate was then computed from the corresponding calibration
curve.

Binding with Con A and E. coli.
The binding affinity of FSNP-labeled Man, FSNP-Man, was evaluated using Con A
and E. coli strain ORN178 and ORN208 according to the following procedure. FSNPMan (2.5 mg) were incubated in a pH 7.2 HEPES buffer solution (1 mL, 10 mM)
containing 3% BSA for 30 min, centrifuged, and the particles were incubated in the
pH 7.2 HEPES solution without BSA for another 20 min. The nanoparticles were
subsequently treated with a solution of Con A in HEPES buffer (1 mL, 10 g/mL)
containing MnCl2 (1 mM) and CaCl2 (1 mM), or E. coli solution for 1 hour while
shaking. In cases where aggregation was induced after binding with Con A, the
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suspension was transferred to a centrifuge tube and was centrifuged at 8,000 rpm for
10 min.

Fabrication of lectin microarrays.
Aldehyde-coated glass slides were prepared following a reported procedure.224
Piranha-cleaned glass slides were treated with a solution of 3-(trimethoxysilyl)butyl
aldehyde in toluene (2 mM) for 4 hours, rinsed with toluene and dried with N2.
Solutions of lectins were prepared in pH 7.4 phosphate-buffered saline (PBS) at
varying concentrations of 0.1-1 mg/mL with 40% glycerol added to prevent
evaporation of the liquid droplets after printing. Con A and SBA were then printed
onto the aldehyde-functionalized glass slide using a robotic printer (BioOdyssey
Calligrapher miniarrayer; Bio-Rad Laboratories, Inc.). The glass slides were then
incubated in a humid chamber (80% humidity) at 25 oC for 3 h to facilitate the
immobilization of the lectins. After incubation, the blocking solution of BSA in pH
7.4 PBS buffer (1%) was added and the slides were incubated for 1 h, rinsed with the
PBS buffer and was dried with N2.

Microarray assay and fluorescence imaging.
The lectin microarrays were incubated in the solution of glyco FSNPs in HEPES (2.5
mg/mL) for 2 h, and were then gently rinsed with the HEPES buffer 3 times and dried.
The slides were scanned under a microarray scanner (GenePix 4000B, Molecular
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Devices, Inc) at excitation of 532 nm. The fluorescent images were recorded and the
data were analyzed using the supplied software (Axon GenePix Pro 5.1).

Results and discussion

Figure 5.5 (a) Synthesis of PFPA-functionalized FSNPs, and (b) high-throughput
synthesis of glyco FSNPs.
Fluorescein (FITC)-doped silica nanoparticles were synthesized using a modified
Stöber

method.162

Fluorescein

isothiocyanate

was

silanized

with

3-

aminopropyltriethoxysilane yielded FITC-silane (Figure 5.5a, which was then
copolymerized with tetraethyl orthosilicate.214,217 The resulting FSNPs, ~100 nm in
diameter, showed intense fluorescence even at low particle concentrations . To test
whether the entrapped FITC can withstand the UV irradiation condition used for
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the photocoupling reaction, a solution of FSNPs was irradiated with a 450-W
medium-pressure Hg lamp for 10 min. The resulting solution remained highly
fluorescent, and the fluorescence intensity decreased only to a small extent. On the
other hand, when a solution of FITC was irradiated under the same condition, the
fluorescence intensity was reduced to about 50% of the original value (Figure 5.11
and 5.12 in Supporting Information) These results are consistent with the
observations by others that the photostability is significantly improved when
fluorescent dyes are embedded in silica nanoparticles.219,225

Next, FSNPs were functionalized with PFPA by treating the as-prepared FSNPs
with PFPA-silane (Figure 5.5a).125 To covalently label carbohydrates with FSNPs,
our previously established procedure for coupling carbohydrates on gold
nanoparticles was followed.155,181 In the process, a solution containing the
carbohydrate and FSNPs was irradiated with a medium-pressure Hg lamp for 10
min (Figure 5.5b). Excess reagents were removed by dialysis, and the resulting
glyco FSNPs showed excellent water solubility and high fluorescence emission
intensity. The density of the immobilized carbohydrate was determined using a
previously developed colorimetric assay,181 from which the coupling yields were
calculated. The results showed that the photocoupling reaction was highly efficient.
The coupling yield, ranging from 36% to 54% (Table 5.2 in Supporting
Information), increased with the size of the carbohydrate, a result that is consistent
with our previous study using gold nanoparticles.181
126

The labeling process is well adaptable for high-throughput where the
photocoupling step can be performed in parallel. A pilot study was carried out
where four micro-vials containing PFPA-FSNPs and four different carbohydrates
were photoactivated simultaneously. The products showed successful conjugation
of each carbohydrate on the FSNPs. The number of reaction wells can be further
increased by using the microarray technology to enable a rapid parallel synthesis of
larger libraries of FSNP-labeled ligands.

Figure 5.6 Fluorescence spectra of (a) FSNP-Man and (b) FSNP-Gal before (black
lines) and after (red lines) incubating with Con A; (c) DLS of Man-FSNPs before (red)
and after (green) binding with Con A; (d) TEM image of Man-FSNPs after treating
with Con A.
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The bioactivity of FSNP-labeled carbohydrates was tested in the following studies.
D-Mannose labeled with FSNP, FSNP-Man, was treated with Concanavalin A
(Con A), a well-studied lectin which exhibits specific affinity to -Dmannopyranoside, -D-glucopyranoside, and their derivatives.114,183 At pH>7, Con
A exists as a tetramer, inducing significant nanoparticle agglomeration upon
binding to Man-containing ligands.181 When FSNP-Man was incubated with Con A
for 1 hour, the fluorescence intensity of the solution decreased drastically (Figure
5.6a). Precipitates were observed where the nanoparticles agglomerated into
clusters (Figure 5.6d). In contrast, when FSNP-labeled D-galactose, FSNP-Gal,
was treated with Con A following the same procedure, the fluorescence intensity
decreased only slightly (Figure 5.6b). The small intensity decrease is likely due to
the nonspecific adsorption of Con A on the nanoparticles. The FSNP-Man-Con A
aggregates were additionally examined by dynamic light scattering (DLS), which
showed, on the average, a 10-time increase in the particle size in comparison to
FSNP-Man (Figure 5.6c).
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Figure 5.7 TEM images after FSNP-Man was treated with E. coli strain ORN178 (a),
or ORN208 (b). Insert: fluorescence image of the corresponding sample. Scale bars:
500 nm.
The utility of the FSNP labeling technique was next investigated by applying glyco
FSNPs in imaging, and for studying glycan-lectin interactions on a lectin
microarray. In the first experiment, FSNP-Man was treated with E. coli bacteria
strain ORN 178. This particular strain contains a Man-specific binding domain,
i.e., the FimH lectin, on type 1 pili.226,227 The TEM image of the resulting solution
displays a large number of FSNP-Man on the E. coli (Figure 5.7a), which can be
attributed to the multivalent interactions between Man ligands on the FSNP-Man
with the FimH lectin on the bacteria.140 The strong interaction was further
confirmed by fluorescence imaging where intense fluorescence was observed on
the bacteria (Figure 5.7a insert). In contrast, when FSNP-Man was treated with E.
coli strain ORN208 that is deficient of the Man-binding FimH protein, no
fluorescence was observed on the bacteria. In fact, almost no nanoparticles were
attached to the bacteria surface (Figure 5.7b).
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Figure 5.8 (a) Preparation of lectin microarray, incubation with FSNP-Man, and
fluorescence imaging. (b) Fluorescence image and (c) fluorescence intensities of lectin
microarray after treating with FSNP-Man. Each data point was the average of the 7
spots on the microarray.
The FSNP-labeled carbohydrates were next employed to study carbohydrate-lectin
interactions on a lectin microarray. The lectin microarray was fabricated on
aldehyde-functionalized

glass

slides

following

the

established

literature

procedure.224 Solutions of Con A and soybean agglutinin (SBA, a non-Manbinding lectin) in pH 7.4 phosphate-buffered saline (PBS) containing 40% glycerol
were then printed on the aldehyde slides using a robotic printer.228 The lectin array
slide, after blocking with bovine serum albumin (BSA), was incubated in the
FSNP-Man solution for 2 hours (Figure 5.8a). As anticipated, fluorescence was
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observed on all Con A spots (Figure 5.8b). The relative fluorescence intensity on
Con A were ~10 times higher than those on SBA at the printing concentration of 1
mg/mL (Figure 5.8c). Even at 0.1 mg/mL, the fluorescence intensity from Con A
was still noticeably higher than that from SBA, although the spot quality
deteriorated at lower printing concentrations. These results clearly demonstrate that
the FSNP-labeled carbohydrates are highly suited for interrogating carbohydratelectin interactions on microarray. Due to the irreversible agglomeration upon the
interactions, the binded nanoparticles were found difficult to be displaced by other
ligands. However, in order to extensively evaluate the specificity and apparent
affinity of glyco FSNPs to lectin microarray, we currently developed an alternative
competition-based assay, with unlabelled ligands added with FSNPs during the
incubation. The preliminary results showed the florescence intensity was highly
affected by concentration of free ligand competitors, and calculated affinities of
FSNPs were several orders of magnitudes higher than that of monovalent binding
in solution.

Conclusion
In conclusion, a simple and general method was developed to label carbohydrates with
dye-doped silica nanoparticles. The strategy applies to underivatized carbohydrate
structures, thus avoiding complex synthesis and purification steps that are often
involved in the chemical derivatization of these ligands. The labeling is highly
efficient, and the resulting FSNP-labeled carbohydrates retained their binding affinity
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and selectivity towards lectins. The utility of this labeling technique was successfully
demonstrated where FSNP-labeled carbohydrates were applied in bacteria detection
and imaging, and in probing glycan-lectin interactions on microarray. These results
illustrate that, although the labeling chemistry, i.e., the CH insertion reaction of PFPA,
yields a random orientation of the attached ligands, the labeled ligands retain their
binding selectivities nonetheless. Further, the labeling reaction may allow the
exposure of all epitopes on the ligands, and thus a biased epitope selection can be
avoided. The technique developed can in principle be readily applied to other
biologically significant molecules including pharmaceuticals and metabolites. The
advantage of this method resides in its generality and simplicity, where the labeling
process employs a single labeling agent, PFPA-FSNP, and a uniform coupling
chemistry. Ligands are labeled in their native forms without undergoing prior
chemical derivatization. These features, combined with the straightforward
preparation of dye-doped silica nanoparticles and the low material cost, may open up a
myriad of opportunities for this technique in bioanalysis and diagnostic applications.
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Supporting Information
TEM and DLS characterization of FITC-doped SNPs

Figure 5.9 TEM image of FITC-doped SNPs. (Scale bar: 0.2 m)

Figure 5.10 Size distribution of FITC-doped SNPs measured by DLS.
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Photo-stability of FITC-doped silica nanoparticles and FITC

Figure 5.11 Fluorescence spectra of FITC-doped silica nanoparticles before and after
UV irradiation for 10 min.

Figure 5.12 Fluorescence spectra of FITC before and after UV irradiation for 10 min.
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Determination of immobilized carbohydrate density and coupling yield

Table 5.2 Ligand density and coupling yield of glyco FSNPs
Carbohydrate ligand

No. of ligand per
FSNP (x104,
experimental)

No. of ligand per
FSNP (x104,
calculated)

Coupling
yield (%)

D-Mannose (Man)

5.52

15.3

36

-1,2-Mannobiose
(Man2)

2.72

5.56

49

-1,3-1,6-Mannotriose
(Man3)

2.48

4.76

52

D -Glucose (Glc)

5.64

15.3

37

Maltopentaose (Glc5)

1.72

3.16

54
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5.3 High-throughput Glycan Screening on Lectin Microarray

Microarrays have become increasingly used in biological research for large-scale
ligand profiling, owing to its features of high-throughput signal output and fast data
analysis. Frequently, glycan microarrays are fabricated which are subsequently
employed to study glycan-lectin interactions using fluorescently-labeled lectins.51,80
An alternative configuration is to construct lectin microarrays which can then be
probed with labeled glycans. Protein microarrays are more developed than glycan
microarrays, and they can be fabricated using established procedures224,229 or acquired
from commercial sources.230 Glycan labeling, however, can be challenging. Unlike
proteins that can be readily labeled using commercially available kits, labeled glycans,
on the other hand, are not easy to obtain. One strategy is to label glycoproteins. In the
study done by Hirabayashi and coworkers, an glycan profiling technique was
described based evanescent-field fluorescence detection strategy. The interactions
between lectin microarrays fabricated on epoxy-derivatized slides and fluorescent
Cy3-tagged glycoproteins, glycopeptides and tetramethylrhodamine (TMR)-labeled
oligosaccharides were monitored, and the dissociation constants were also determined
by competition assays.213

We have demonstrated that dye-doped silica nanoparticles provided an attractive
platform to label glycans for the recognition of carbohydrate-binding proteins, lectins.
Because multiple dye molecules are trapped inside the NPs, the resulting fluorescent
nanoparticles are brighter than single dye molecule, and the fluorescent intensity is
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more stable towards photobleaching and environmental degradation.215,228 In the
previous chapter, we demonstrate that the FSNP-labeled glycans are effective in
probing lectin microarrays. In this chapter, a novel “super-microarray” design will be
adapted where FSNP-labeled glycans will be used to study glycan-lectin interactions
in high throughput. The super-microarray differs from the conventional microarray
that it consists of multiple microarrays (Figure 5.13). By applying a poly(dimethyl
siloxane) (PDMS) isolator, each microarray can be isolated and therefore different
assays can be conducted in each individual microarray (Figure 5.13).

Figure 5.13 Schematics of lectin super-microarray fabrication, and the subsequent assays
with glyco-FSNPs.
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The super-microarrays can be used for high throughput screening of ligands (Figure
5.14a) and for high throughput competition assays to determine binding affinity of
glycan-lectin interactions (Figure 5.14b). Both applications will be demonstrated in
this Chapter where FSNP-labeled glycans will be used on lectin supermicroarrays.
Competition assays will be carried out simultaneously on a single super-microarray,
from which IC50 values will be derived and the binding affinity calculated. This
provides a high throughput method to determine binding affinity of glycan-lectin
interactions.

Figure 5.14 Schematics of (a) high-throughput screening, and (b) competition assay
on super microarrays.

Experimental details
Preparation of FITC-doped glyconanoparticles.
See section 5.2166
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Fabrication of lectin super-microarrays.
The lectin super-microarray was prepared on an epoxy-coated glass slide. Glass slides
were firstly cleaned in Piranha solution (conc. H2SO4/H2O2, 1:1, v:v), followed by
soaking in a toluene solution of 3-glycidyloxypropyltrimethoxysilane (12.6 mM,
>95%, TCI America; Portland, OR) for 4 hours, rinsed thoroughly with toluene and
dried with nitrogen. Con A (Concanavalin A), BSA (Bovine serum albumin), SBA
(Soybean Agglutinin), PNA (Peanut Agglutinin), BS-I (Bandeiraea simplicifolia)
(Sigma-Aldrich; St. Louis, MO), DBA (Dolichos Biflorus Agglutinin), UEA (Ulex
Europaeus Agglutinin I), WGA (Wheat Germ Agglutinin) and RCA (Ricinus
Communis Agglutinin I) (Vector Laboratories; Burlingame, CA) were used as
received. The concentration of Con A was determined spectrophotometrically at 280
nm using A1%, 1cm= 13.7 at pH 7.2.136 CV-N (Cyanovirin-N) and OAA (Oscillatoria
Agardhii Agglutinin) wild-type lectins and CN-V mutants CVNQ50C and CVNMutDB
were supplied by Professor Angela M. Gronenborn’s research laboratory at University
of Pittsburgh. Lectin solutions were prepared in phosphate-buffered saline at
concentrations of 1 mg/mL (except PNA and RCA at 0.25 mg/mL) with 40% glycerol
added to prevent complete drying of the liquid droplets after printing. A volume of
0.3mL lectin solution was added to the microtiter plate well and the solutions were
spotted onto the epoxy-coated glass slides using a robotic printer (BioOdyssey
Calligrapher Mini-arrayer; Bio-Rad Laboratories, Inc.) and capillary pin of ~360M
size. Each spot was printed 5 times. Each lectin was printed with 5 duplicate spots.
The glass slides were then incubated in a humid chamber (80% humidity) at 25 oC for
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3 h to facilitate the immobilization of the lectins. A SecureSeal™ hybridization
chambers sheet (Grace Bio-lab, Bend, OR) was carefully placed on the glass slide to
create 16 individual wells.213 A blocking solution of BSA in pH 7.4 PBS buffer (1%)
was then added to each well and the slide was incubated at room temperature for 1 h,
rinsed with the PBS buffer and was dried with N2.

Treating supermicroarray with glyco-FSNP.
The lectin supermicroarrays were incubated in the solution of glyco FSNPs in HEPES
(1.5 mg/mL) for 2 h; for the competition assays, 1nM to 1mM free ligand Man2 was
added in each well with FSNP-Man2 (1.5mg/mL); and were then gently rinsed with
the HEPES buffer containing 0.1% Tween 20 for 3 times and dried with N2. The slides
were scanned under a microarray scanner (GenePix 4100A, Molecular Devices, Inc) at
excitation of 532 nm. The fluorescent images were recorded and the data were
analyzed using the supplied software (Axon GenePix Pro 5.1).

Results and discussion
Optimization of super-microarrays and assay conditions
Lectin microarrays were prepared following a literature procedure by immobilizing
lectins on epoxy-functionalized surfaces.224 Piranha-cleaned glass slides were treated
with an epoxy-silane, GPTMS (Figure 5.13). Lectin solutions in PBS containing
glycerol were then printed onto GPTMS-modified glass slides using a microarray
printer. Multiple lectin microarrays were printed on the same glass slide where each
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microarray was separated by a 16-well PDMS isolator to give a super-microarray with
16 individual microarray on a single slide (Figure 5.13).

The lectin super-microarrays were tested for their ability for screening carbohydrate
ligands. The carbohydrates were labeled with FITC-doped silica nanoparticles. We
have demonstrated previously that dye-doped silica nanoparticles can efficiently label
glycans.166 Because multiple dye molecules are trapped inside silica nanoparticles, the
resulting FSNPs are brighter and the fluorescence is more stable than the free dye
molecules as they are protected by the nanoparticles.215 FSNPs of 110 nm diameter
were synthesized,166 and carbohydrate ligands were conjugated onto the fluorescent
nanoparticles using the previously developed PFPA photocoupling chemistry to yield
FSNP-labeled carbohydrates, glyco-FSNPs (Figure 5.13).125,166,181

The binding experiments were conducted by incubating buffer solutions containing
glyco-FSNPs in each well on the lectin super-microarray. After rinsing with the fresh
buffer and drying, the slide was subjected to a microarray scanner and the
fluorescence image was recorded. The lectin printing concentration, the concentration
and incubation time of glyco-FSNPs were varied to study the impact of these
experimental conditions on the binding results. Figure 5.15a shows that when Man2FSNPs were incubated with Con A, the fluorescence intensity increased linearly with
the Con A printing concentration from 0.1 to 2.5 mg/mL. Similarly, the fluorescence
intensity increased with the concentrations of Man2-FSNPs from 0.05 to 1.0 mg/mL
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(Figure 5.15b). The incubation time was then varied while keeping concentrations of
Con A and Man2-FSNPs at 1 mg/mL, and 1.5 mg/mL, respectively. As shown in
Figure 5.15c, the intensity increased until 75 min and reached saturation after 2 hours.
The incubated lectin spots were characterized by AFM. Images show that the spot was
fairly uniformly covered with FSNPs (Figure 5.16). More than single layer of FSNPs
was observed in some areas, most likely due to nanoparticle agglomeration
before/during incubation. In a control experiment where a non-binding lectin, SBA,
was treated with Man2-FSNPs, the signals remained low until after 2 hours, and
increased afterwards because of the non-specific adsorption (Figure 5.15c). To
minimize particle agglomeration and non-specific adsorption, the glyco-FSNP
concentration and the incubation time were kept at 1.5 mg/mL and 2 hours,
respectively, for subsequent studies.
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Figure 5.15 Interactions of Man2-FSNPs with super-microarray: (a) fluorescence
intensity vs. the printing concentration of Con A (□); (b) fluorescence intensity vs. the
concentration of Man2 -FSNPs (○); (c) fluorescence intensity vs. Man2-FSNPs (1.5
mg/mL) incubation time (inserts: fluorescence images of Con A spots (top panel) and
SBA spots (bottom panel)). The concentration of Man2-FSNPs in (a) was 1.5 mg/mL,
and the printing concentration of Con A was 1 mg/mL in (b). Each data point was the
average of five duplicate spots on the array. The lines were drawn to aid visualization

Figure 5.16 Fluorescence (a) and AFM images (b-d) of a printed Con A spot (1
mg/mL) after incubation with Man2-FSNP (1.5 mg/mL) for 2 h.
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Super-microarrays for high-throughput ligand screening
In this study, we evaluate the application of lectin super-microarrays in screening
carbohydrate ligands using glyco-FSNPs. A total of 14 lectins were used; their binding
carbohydrate ligands are listed in Table 5.3. The lectin microarrays were fabricated
following the same protocols and parameters developed in the section described above.
Due to the size limitation of the PDMD isolator and printing spot size, only 7 lectins
could fit in one isolator well, and therefore, the 14 lectins were divided into two
groups. The lectins were printed on GPTMS-functionalized glass slides in 7 x 5 array,
and the array was repeated in 2 x 8 array format to create 16 microarrays on each chip
(Figure 5.13). Figure 5.17 lists the carbohydrate ligands used in this study. Each ligand
was coupled on FSNPs following the protocol described above, and the surface
density was similar to what was reported in our previous study.166 In the binding
experiments, a 2 x 8 PDMS isolator was placed on the lectin super-microarray slide to
create 16 wells, and different glyco-FSNPs were incubated in each individual well
containing the 7 x 5 lectin microarray.
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Table 5.3 Lectins and their corresponding carbohydrate binding ligands.
Lectin

Origin

Binding ligands

CVN-Q

Cyanovirin-N Q50C

Cyanobacteria

-1,2-Man

CVN-M

Cyanovirin-N MutDB

Cyanobacteria

-1,2-Man

SBA

Soybean Agglutinin

Glycine max
(soybean)

GalNAc

BSA

Bovine serum albumin

Bovine serum

N/A

Con A

Concanavalin A

Canavalia ensiformis

Man

PNA

Peanut Agglutinin

Arachis hypogaea
(peanut)

Gal(-1,3)
GalNAc /Gal

BS-I

Bandeiraea
simplicifolia

Griffonia
(Bandeiraea)
simplicifolia seeds

GalNAc, and Gal

OAA

Oscillatoria Agardhii
Agglutinin

Cyanobacteria

-1,6-Man

PFA

Homolog of OAA

N/A

-1,6-Man

W77

Mutant of OAA

Cyanobacteria

-1,6-Man

DBA

Dolichos Biflorus
Agglutinin

Dolichos biflorus
(horse gram) seeds

GalNAc

UEA

Ulex Europaeus
Agglutinin I

Ulex europaeus
(Furze gorse) seed

L-fucose

WGA

Wheat Germ
Agglutinin

Triticum vulgaris
(wheat germ)

GlcNAc

RCA

Ricinus Communis
Agglutinin I

Ricinus communis
(castor bean) seeds

Gal/ GalNAc/ Lac
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Figure 5.17 Carbohydrate structures used in this study.

Results of the microarray analysis are shown in Figure 5.18. The binding pairs such as
2-Man2/2, 2-Man3 with CVNs/Con A, Man with Con A, Gal with PNA/BS-I, as
well as 6-Man2/3, 6-Man3 with OAA/PFA, Fuc with UEA and Glc with WGA
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show noticeably higher intensities than those non-binding pairs. The results were
consistent with the affinity of these glycan-lectin pairs (see association constants
shown in Table 5.4), demonstrating the high selectivity of the super-microarrays. The
signal intensities also revealed the relative binding affinities of glycan ligands with
lectins. For instance, Con A that is a tetrameric protein having saccharides binding
sites to -Man and -Glc in the affinity order of 2, 2-Man3 (3.79x105 M-1)> 2Man2 (4.17x104 M-1)>Man (8.2x103 M-1)>Glc (1.96x103 M-1) (Table 5.4). In this
study, Con A spots showed the highest intensity for 2, 2-Man3 and the lowest for
Glc and derivatives (GlcNAc and Lac), and minimal signal was detected for the nonbinding ligand Gal (Figure 5.18). Another group of lectins studied were CV-N mutants
Q50C and MutDB. These are anti-HIV lectins that recognize -1,2 linked Man structures
such as 2-Man2 and 2, 2-Man3 (Table 5.4). The natural ligand is Man9, an
oligosaccharide that is difficult and expensive to obtain.184 We have shown in Chapter
5.1 that by conjugating the epitope structure of lower Man structures such as 2-Man2
and 2, 2-Man3 to gold nanoparticles, the affinity of the resulting glyconanoparticles
were increased several orders of magnitude.189 These epitope ligands labeled with
SFNPs were therefore used in the present studies to probe lectin microarrays. Results
in Figure 5.18 shows that 2, 2-Man3 conjugated on FSNP exhibited higher
fluorescent density than Man2-FSNP, which correlated well with the affinity ranking
of the free ligands (Table 5.4) as well as the ITC188 and gold GNP189 studies. Similar
results were also observed for other lectin-glycan binding pairs that the array results
were consistent with the affinity rank order of the corresponding free ligands.
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Table 5.4 Association constants (Ka) of lectins and glycans.
Lectin

2-Man2

Ka (M-1)
1.43x103 (Domain A); 1.56x104
(Domain B)
2.94x105 (Domain A); 2.33x104
(Domain B)
1.32x103

2, 2-Man3

2.94x105

Man

8.2x103

2-Man2

4.17x104

2, 2-Man3

3.79x105

Glc

1.96x103

GalNAc

1.51x106

Gal

0.98x103
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Figure 5.18 Fluorescence image (a, c) and fluorescence intensity (b, d) of lectin supermicroarrays interacting with glyco-FSNPs.
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Super-microarrays for high throughput binding affinity determination
The 2 x 8 PDMS isolator creates 16 individual microarrays, and therefore, 16 different
assays can be carried out simultaneously on a single super-microarray. When 16
ligand competition assays are performed, a dose-response curve can be plotted, from
which the IC50 value can be derived and the dissociation constant subsequently
calculated. This provides a high throughput means to determine binding affinity from
a single super-microarray.

Competition binding assays were performed by mixing free competing ligands of
varying concentrations with a fixed concentration of glyco-FSNPs and the resulting
solutions were transferred to the wells on the super-microarray. Figure 5.19 showed a
typical fluorescence image of the lectin super-microarray after incubating with Man2FSNP and varying concentration of 2-Man2. It can be seen that only the binding
lectins for 2-Man2 (CVN-Q, CVN-M and Con A) exhibited strong and different
signals with varying concentrations of 2-Man2. Further, the fluorescence intensity
decreased with increasing 2-Man2 concentration, which was anticipated since 2Man2 competed with Man2-FSNP for binding the lectins on the array. By plotting the
fluorescence intensity against the concentration of 2-Man2, a dose response curve
was obtained, from which the IC50 value can be derived. Figure 5.19b-d show the
results from the three binding lectins CVN-Q, CVN-M and Con A. Following a
revised Cheng-Prusoff equation
KD=IC50/(1+[M]/Kd)
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where Kd is the dissociation constant of the free ligand with the corresponding lectin,
KD, the apparent dissociation constant of immobilized lectin with glyco-FSNP was
calculated,154,206 and results are shown in Table 5.5.

Figure 5.19 (a) Fluorescence image of a lectin super-microarray after incubating with
Man2-FSNP and varying concentrations of 2-Man2. (b-d) Fluorescence intensities
vs. free 2-Man2 concentration for CVN-Q CVN-M (c) and Con A (d). Insert in (b)
shows the fluorescence images of the corresponding spots.
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Table 5.5 Apparent KD values of glyco-FSNPs with lectins obtained from supermicroarrays.
Ligand density

CVN-Q

CVN-M

Con A

1.66 nM

0.43 nM

0.0083 nM

(15.5 M)

(3.4 M)

(2.97M)

16.6 nM

589 nM

5.40 nM

(89.8 M)

(757 M)

(24 M)

4.2

N/D

N/D

4.3

N/D

N/D

(ligand/nm2)1
FSNPMan3
FSNPMan2
FSNPMan
FSNPGal

1.3
1.5

13.7 nM
(470 M)
N/D

PNA
N/D3
N/D
N/D
114 nM
(1050 M)

1

Ligand density was measured by anthrone-H2SO4 colorimetric method.
The data in brackets are dissociation constants of the free ligand with the lectin.
3
N/D= not detectable.
2

A dramatic increase in affinity was observed when glycans attached on nanoparticle
surface. Results showed that the multivalent presentation of carbohydrate ligands
significantly enhanced the binding affinity of FSNPs by 4~6 orders of magnitude in
comparison to the free ligands in solution. In addition, the apparent affinity of FSNPGal with its binding lectin PNA was determined as well, and similarly KD was 7
orders of magnitude lower than Kd of free galactose ligand. The apparent KD values
(Table 5.5) were comparable to those obtained using other microarray platforms, such
as surface plasmon resonance235,236 and evanescent-field fluorescence.213
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Conclusion
A new platform has been developed to study glycan-lectin interactions. It is based on
lectin microarrays which are probed with glycans labeled with dye-doped
nanoparticles. This labeling technique has several key advantages. First, the coupling
chemistry is highly general and can be applied to a wide range of glycans including
higher glycan structures, underivatized carbohydrates, as well as reducing sugars.237
Secondly, compared with fluorescent dyes, dye-doped nanoparticles provide higher
fluorescence intensity and much improved photo-stability. The labeled glycans can be
readily purified by dialysis thus avoiding the potential complex solution-phase
purification procedure when fluorescent dyes are used. Thirdly, multiple copies of the
glycan can be conjugated on one nanoparticle introducing multivalency effect that
significantly enhances their interactions with lectins.

The lectin super-microarrays further increase the throughput of microarrays by
creating multiple microarrays on the same chip. Thus different assays can be
performed simultaneously permitting large-scale glycan profiling. Furthermore, ligand
competition assays can be conducted on a single super-microarray to afford the dose
response curve, from which the IC50 and apparent KD values can be readily obtained.
This represents a new analytical method for affinity measurement. Compared with the
reported methods of nuclear magnetic resonance (NMR),238 enzyme-linked
immunosorbent

assay

(ELISA),239

isothermal

titration

calorimetry

(ITC),240

precipitation inhibition,241 equilibrium dialysis,242 spectrophotometry,243 fluorescence
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competition

assay,155

surface

plasmon

resonance

(SPR),236,244

carbohydrate

microarrays,204 and quartz-crystal microbalance (QCM),245,246 our method allows for
high-throughput data outputs and much reduced glycan consumption (only ~3 g of
glycans consumed for each assay). The high throughput nature of lectin supermicroarrays in conjunction with the versatility of nanoparticle-based glycan labeling
technique provides a robust and unique approach ideally suited for quantitative glycan
profiling in a large library. The protocol could also be applied to other biological
entities such as DNA, antibodies, and cells. The technology presented herein thus
opens new opportunities facilitating the development of glycomics as well as
application in disease diagnosis and therapeutics.
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Chapter 6. Conclusion

Merging nanotechnology with biology has seen exponential growth of research
activities in functional bio-nanomaterials. Nanomaterials in general, and
glyconanoparticles in particular, are witnessing a tremendous interest for a wide range
of applications in chemistry, biology and medicine, and their merits are well known in
comparison to other formats. Essential to glyconanoparticle preparation is the
conjugation chemistry that can efficiently attach carbohydrates to the nanomaterials.
We developed a simple and versatile photocoupling chemistry that allows the covalent
immobilization of a wide range of carbohydrate structures to nanomaterials, including
gold and fluorescent silica nanoparticles. The coupling reaction was efficient and high
yielding, and the resulting surface-bound carbohydrate ligands retained their binding
affinities and selectivities. The development of new analytical methods to characterize
glyconanoparticle-protein interactions, including fluorescence competition assays,
dynamic light scattering and isothermal calorimetry, highlight the importance of
quantitative analysis of structural and functional properties of glyconanomaterials,
especially the biorecognition properties that must be carefully analyzed in the context
of ligand presentation and display. Results from my studies have shown that
glyconanoparticles are highly potent - potentially superior - vehicles for targeting
carbohydrate-mediated biological effects due to the multivalency effects commonly
associated with carbohydrate-protein interactions. Nanoparticles as carriers can greatly
enhance the binding affinity of the carbohydrate ligands, and in addition, the affinity is
155

significantly impacted by the carbohydrate presentation on nanoparticle surfaces,
which could be applied for enhanced recognition of biologically significant lectins,
such as anti-HIV CV-N in our study. The new glycan label, dye-doped silica
nanoparticles, greatly facilitated the high-throughput labeling using nanomaterials as
the scaffold, and FSNP-labeled glycans have shown potential applications in protein
recognition, bacteria imaging, and high-throughput glycan screening on lectin
microarrays. With the wealth of existing results on glyconanomaterials and their
demonstrated multivalent interactions with proteins, advanced developments in
therapeutic and diagnostic applications based on biologically-functionalized
nanomaterials are poised to evolve.
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